Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Nuclear Medicine

  Free Subscription


Articles published in J Nucl Med

Retrieve available abstracts of 575 articles:
HTML format
Text format



Single Articles


    February 2017
  1. EINSPIELER I, Rauscher I, Duwel C, Kronke M, et al
    Detection efficacy of hybrid 68Ga-PSMA ligand PET/CT in prostate cancer patients with biochemical recurrence after primary radiation therapy defined by Phoenix criteria.
    J Nucl Med. 2017 Feb 16. pii: jnumed.116.184457. doi: 10.2967/jnumed.116.184457.
    PubMed     Text format     Abstract available


  2. ZHANG-YIN J, Dirand AS, Sasanelli M, Correge G, et al
    Equivalent dose rate at 1m of patients with known or suspected neuroendocrine tumor exiting a nuclear medicine department after 68Ga-DOTATOC, 18F-FDOPA or 18F-FDG PET/CT, or 111In-pentetreotide or 123I-mIBG SPECT/CT.
    J Nucl Med. 2017 Feb 16. pii: jnumed.116.187138. doi: 10.2967/jnumed.116.187138.
    PubMed     Text format     Abstract available


  3. ANNARITA S, Incerti E, Fallanca F, Bettinardi V, et al
    First evaluation of PET based human biodistribution and dosimetry of 18F-FAZA, a tracer for imaging tumor hypoxia.
    J Nucl Med. 2017 Feb 16. pii: jnumed.113.122671. doi: 10.2967/jnumed.113.122671.
    PubMed     Text format     Abstract available


  4. SOLNES LB, Jones KM, Rowe SP, Pattanayak P, et al
    Diagnostic Value of 18F-FDG PET/CT versus MRI in the Setting of Antibody Specific Autoimmune Encephalitis.
    J Nucl Med. 2017 Feb 16. pii: jnumed.116.184333. doi: 10.2967/jnumed.116.184333.
    PubMed     Text format     Abstract available


  5. BULLICH S, Villemagne VL, Catafau AM, Jovalekic A, et al
    Optimal reference region to measure longitudinal amyloid-beta change with 18F-florbetaben PET.
    J Nucl Med. 2017 Feb 9. pii: jnumed.116.187351. doi: 10.2967/jnumed.116.187351.
    PubMed     Text format     Abstract available


  6. GRKOVSKI M, Schoder H, Lee N, Carlin SD, et al
    Multiparametric imaging of tumor hypoxia and perfusion with 18F-FMISO dynamic PET in head and neck cancer.
    J Nucl Med. 2017 Feb 9. pii: jnumed.116.188649. doi: 10.2967/jnumed.116.188649.
    PubMed     Text format     Abstract available


  7. KOLBITSCH C, Ahlman MA, Davies-Venn C, Evers R, et al
    Cardiac and respiratory motion correction for simultaneous cardiac PET-MR.
    J Nucl Med. 2017 Feb 9. pii: jnumed.115.171728. doi: 10.2967/jnumed.115.171728.
    PubMed     Text format     Abstract available


  8. FUCHS K, Kuehn A, Mahling M, Guenthoer P, et al
    In vivo hypoxia PET imaging quantifies the severity of arthritic joint inflammation in line with overexpression of HIF and enhanced ROS generation.
    J Nucl Med. 2017 Feb 9. pii: jnumed.116.185934. doi: 10.2967/jnumed.116.185934.
    PubMed     Text format     Abstract available


  9. LE D
    The Mathematics and Biology of the Biodistribution of Radiopharmaceuticals - A Clinical Perspective.
    J Nucl Med. 2017 Feb 9. pii: jnumed.117.191312. doi: 10.2967/jnumed.117.191312.
    PubMed     Text format    


  10. MENDA Y, O'Dorisio TM, Howe J, Schultz MK, et al
    Localization of Unknown Primary Site with 68Ga-DOTATOC PET/CT in Patients with Metastatic Neuroendocrine Tumor.
    J Nucl Med. 2017 Feb 2. pii: jnumed.116.180984. doi: 10.2967/jnumed.116.180984.
    PubMed     Text format     Abstract available


    January 2017
  11. RENAUD JM, Moody JB, deKemp RA
    Reply: Variation in maximum count rates during myocardial blood flow quantification using Rubidium-82 PET.
    J Nucl Med. 2017 Jan 26. pii: jnumed.116.188086. doi: 10.2967/jnumed.116.188086.
    PubMed     Text format    


  12. WADSWORTH BJ, Pan J, Dude I, Colpo N, et al
    2-18F-Fluoroethanol is a novel positron emission tomography (PET) reporter of solid tumour perfusion.
    J Nucl Med. 2017 Jan 26. pii: jnumed.116.183624. doi: 10.2967/jnumed.116.183624.
    PubMed     Text format     Abstract available


  13. HEKMAN MC, Rijpkema M, Bos D, Oosterwijk E, et al
    Detection of micrometastases using SPECT/fluorescence dual-modality imaging in a CEA-expressing tumor model.
    J Nucl Med. 2017 Jan 26. pii: jnumed.116.185470. doi: 10.2967/jnumed.116.185470.
    PubMed     Text format     Abstract available


  14. THIE JA
    Need for Glucose Correction for 18F-FDG PET Influenced by Glucose Sensitivities to Types of Tissue and Random Factors.
    J Nucl Med. 2017 Jan 26. pii: jnumed.116.188185. doi: 10.2967/jnumed.116.188185.
    PubMed     Text format    


  15. FUIN N DR, Pedemonte S Dr, Catalano OA, Izquierdo-Garcia D, et al
    PET/MR Imaging in the Presence of Metal Implants: Completion of the Attenuation Map from PET Emission Data.
    J Nucl Med. 2017 Jan 26. pii: jnumed.116.183343. doi: 10.2967/jnumed.116.183343.
    PubMed     Text format     Abstract available


  16. ZWARTHOED C, El-Galaly TC, Canepari M, Ouvrier MJ, et al
    Prognostic value of bone marrow tracer uptake pattern in baseline PET scan in Hodgkin Lymphoma: results from an International Collaborative Study.
    J Nucl Med. 2017 Jan 26. pii: jnumed.116.184218. doi: 10.2967/jnumed.116.184218.
    PubMed     Text format     Abstract available


  17. LI L, Wu Y, Wang Z, Jia B, et al
    SPECT/CT Imaging of the Novel HER2-targeted Peptide Probe 99mTc-HYNIC-H6F in Breast Cancer Mouse Models.
    J Nucl Med. 2017 Jan 19. pii: jnumed.116.183863. doi: 10.2967/jnumed.116.183863.
    PubMed     Text format     Abstract available


  18. GERNGROSS C, Schretter J, Klingenspor M, Schwaiger M, et al
    Active brown fat during 18FDG-PET/CT imaging defines a patient group with characteristic traits and an increased probability of brown fat redetection.
    J Nucl Med. 2017 Jan 19. pii: jnumed.116.183988. doi: 10.2967/jnumed.116.183988.
    PubMed     Text format     Abstract available


  19. VAN DIJK JD, Jager PL, van Osch JA, van Dalen JA, et al
    Variation in maximum count rates during myocardial blood flow quantification using Rubidium-82 PET.
    J Nucl Med. 2017 Jan 19. pii: jnumed.116.187757. doi: 10.2967/jnumed.116.187757.
    PubMed     Text format    


  20. PLYKU D, Hobbs RF, Huang K, Atkins F, et al
    Recombinant human thyroid-stimulating hormone versus thyroid hormone withdrawal in 124I-PET/CT based dosimetry for 131I therapy of metastatic differentiated thyroid cancer.
    J Nucl Med. 2017 Jan 19. pii: jnumed.116.179366. doi: 10.2967/jnumed.116.179366.
    PubMed     Text format     Abstract available


  21. BARRIO M, Czernin J, Fanti S, Ambrosini V, et al
    The impact of SSTR-directed PET/CT on the management of patients with neuroendocrine tumor: A systematic review and meta-analysis.
    J Nucl Med. 2017 Jan 12. pii: jnumed.116.185587. doi: 10.2967/jnumed.116.185587.
    PubMed     Text format     Abstract available


  22. LEBECH AM, Gaardsting A, Loft A, Graff J, et al
    Whole body 18F-FDG PET/CT is superior to CT as first line diagnostic imaging in patients referred with serious non-specific symptoms or signs of cancer: a randomized prospective study of 200 patients.
    J Nucl Med. 2017 Jan 12. pii: jnumed.116.175380. doi: 10.2967/jnumed.116.175380.
    PubMed     Text format     Abstract available


  23. VAN ES SC, Brouwers AH, Mahesh SV, Leliveld-Kors AM, et al
    89Zr-bevacizumab PET: Potential Early Read Out for Efficacy of Everolimus in Metastatic Renal Cell Carcinoma Patients.
    J Nucl Med. 2017 Jan 12. pii: jnumed.116.183475. doi: 10.2967/jnumed.116.183475.
    PubMed     Text format     Abstract available


  24. CHEN DL, Cheriyan J, Chilvers E, Choudoury G, et al
    Quantification of Lung PET Images: Challenges and Opportunities.
    J Nucl Med. 2017 Jan 12. pii: jnumed.116.184796. doi: 10.2967/jnumed.116.184796.
    PubMed     Text format     Abstract available


  25. ZHOU X, Boellaard R, Ishiwata K, Sakata M, et al
    In vivo evaluation of [11C]preladenant for PET-imaging of adenosine A2A receptors in the conscious monkey.
    J Nucl Med. 2017 Jan 6. pii: jnumed.116.182410. doi: 10.2967/jnumed.116.182410.
    PubMed     Text format     Abstract available


  26. ADAMS HJ, Kwee TC
    Fact sheet about interim and end-of-treatment 18F-FDG PET/CT in lymphoma.
    J Nucl Med. 2017 Jan 6. pii: jnumed.116.187815. doi: 10.2967/jnumed.116.187815.
    PubMed     Text format    


  27. SVIRYDENKA H, Delso G, Barbosa FG, Huellner MW, et al
    The effect of susceptibility artifacts related to metal implants on adjacent lesion assessment in simultaneous TOF PET/MR.
    J Nucl Med. 2017 Jan 6. pii: jnumed.116.180802. doi: 10.2967/jnumed.116.180802.
    PubMed     Text format     Abstract available


  28. ARAKAWA Y, Nai Y, Shidahara M, Furumoto S, et al
    Prediction of the clinical standardized uptake value ratio in amyloid PET imaging using a biomathematical modeling approach towards the efficient development of a radioligand.
    J Nucl Med. 2017 Jan 6. pii: jnumed.116.183566. doi: 10.2967/jnumed.116.183566.
    PubMed     Text format     Abstract available


  29. AFSHAR-OROMIEH A, Sattler LP, Mier W, Hadaschik B, et al
    The clinical impact of additional late PET/CT imaging with 68Ga-PSMA-11 (HBED-CC) in the diagnosis of prostate cancer.
    J Nucl Med. 2017 Jan 6. pii: jnumed.116.183483. doi: 10.2967/jnumed.116.183483.
    PubMed     Text format     Abstract available


  30. CZERNIN J
    Molecular Imaging and Therapy with a Purpose: A Renaissance of Nuclear Medicine.
    J Nucl Med. 2017;58:21A-22A.
    PubMed     Text format    


  31. SCHWARZ SW
    SNMMI Leadership Update: FDA Approval of Imaging Agents: An Exciting Investment in Nuclear Medicine.
    J Nucl Med. 2017;58:20N.
    PubMed     Text format    



  32. SNMMI COR Submits Recommendations, White Paper on Compounded Sterile Radiopharmaceuticals to USP.
    J Nucl Med. 2017;58:16N-17N.
    PubMed     Text format    


    December 2016
  33. NOTNI J, Reich D, Maltsev OV, Kapp TG, et al
    In-vivo PET imaging of the "cancer integrin" alphavbeta6 using gallium-68 labelled cyclic RGD nonapeptides.
    J Nucl Med. 2016 Dec 15. pii: jnumed.116.182824.
    PubMed     Text format     Abstract available


  34. SHEIKHBAHAEI S, Marcus C, Fragomeni RS, Rowe SP, et al
    Whole Body FDG-PET and FDG-PET/CT in Patients with Suspected Paraneoplastic Syndrome: A Systematic review and Meta-analysis of Diagnostic Accuracy.
    J Nucl Med. 2016 Dec 15. pii: jnumed.116.183905.
    PubMed     Text format     Abstract available


  35. GOETZ C, Podein M, Braun F, Weber WA, et al
    Influence of animal heating on PET imaging quantification and kinetics: results on the biodistribution of 18F-tetrafluoroborate and 18F-FDG in mice.
    J Nucl Med. 2016 Dec 15. pii: jnumed.116.177949.
    PubMed     Text format     Abstract available


  36. MORIGUCHI S, Kimura Y, Ichise M, Arakawa R, et al
    PET quantification of the norepinephrine transporter in human brain with (S,S)-18F-FMeNER-D2.
    J Nucl Med. 2016 Dec 15. pii: jnumed.116.178913.
    PubMed     Text format     Abstract available


  37. LAFFON E, Marthan R
    Letter: Repeatability of Quantitative Whole Body 18F-FDG PET/CT Uptake Measures in NSCLC Patients: Dynamic versus Test-Retest Design.
    J Nucl Med. 2016 Dec 8. pii: jnumed.116.186676.
    PubMed     Text format    


  38. BHETHANABHOTLA S, Bakhshi S
    Reply: Neither post-treatment PET-CT nor interim PET-CT using Deauville criteria predicts outcome in pediatric Hodgkin lymphoma.
    J Nucl Med. 2016 Dec 8. pii: jnumed.116.186114.
    PubMed     Text format    


  39. CHAE SY, Kim SB, Ahn SH, Moon DH, et al
    Reply: 18F-fluoroestradiol positron emission tomography to predict response to neoadjuvant treatment in luminal breast cancer.
    J Nucl Med. 2016 Dec 8. pii: jnumed.116.185660.
    PubMed     Text format    


  40. LI X, Rowe SP, Leal JP, Gorin MA, et al
    Quantitative Parameters in PSMA-targeted PET Imaging with 18F-DCFPyL: Variability in Normal Organ Uptake.
    J Nucl Med. 2016 Dec 8. pii: jnumed.116.179739.
    PubMed     Text format     Abstract available


  41. TAMAKI N
    2016 SNMMI Highlights Lecture: Cardiovascular Nuclear Medicine.
    J Nucl Med. 2016;57:8N-14N.
    PubMed     Text format    


  42. TREVES ST, Gelfand MJ, Fahey FH, Parisi MT, et al
    2016 Update of the North American Consensus Guidelines for Pediatric Administered Radiopharmaceutical Activities.
    J Nucl Med. 2016;57:15N-18N.
    PubMed     Text format    


  43. SONG J, Yan R, Wu Z, Li J, et al
    13N-ammonia PET/CT detection of myocardial perfusion abnormalities in Beagle dogs after local heart irradiation.
    J Nucl Med. 2016 Dec 1. pii: jnumed.116.179697.
    PubMed     Text format     Abstract available


  44. DIETLEIN F, Kobe C, Neubauer S, Schmidt M, et al
    PSA-stratified performance of 18F- and 68Ga-labeled tracers in PSMA-PET imaging of patients with biochemical recurrence of prostate cancer.
    J Nucl Med. 2016 Dec 1. pii: jnumed.116.185538.
    PubMed     Text format     Abstract available


  45. BARRET O, Alagille D, Sanabria S, Comley RA, et al
    Kinetic Modeling of the Tau PET Tracer 18F-AV-1451 in Human Healthy Volunteers and Alzheimer's Disease Subjects.
    J Nucl Med. 2016 Dec 1. pii: jnumed.116.182881.
    PubMed     Text format     Abstract available


  46. ADAMS HJ, Kwee TC
    Prudence required when using 18F-FDG PET as reference standard for lymphoma detection.
    J Nucl Med. 2016 Dec 1. pii: jnumed.116.187096.
    PubMed     Text format    


    November 2016
  47. HEISS WD, Zaro Weber O
    Validation of MRI Determination on PET Measurements in Ischemic Stroke.
    J Nucl Med. 2016 Nov 22. pii: jnumed.116.185975.
    PubMed     Text format     Abstract available


  48. ELVAS F, Boddaert J, Vangestel C, Pak K, et al
    99mTc-Duramycin SPECT imaging of early tumor response to targeted therapy: a comparison with 18F-FDG PET.
    J Nucl Med. 2016 Nov 22. pii: jnumed.116.182014.
    PubMed     Text format     Abstract available


  49. ULANER GA, Goldman D, Corben A, Lyashchenko S, et al
    A prospective clinical trial of 18F-Fluciclovine PET/CT neoadjuvant therapy response in invasive ductal and invasive lobular breast cancers.
    J Nucl Med. 2016 Nov 17. pii: jnumed.116.183335.
    PubMed     Text format     Abstract available


  50. HATT M, Tixier F, Visvikis D, Cheze Le Rest C, et al
    Radiomics in PET/CT: more than meets the eye?
    J Nucl Med. 2016 Nov 3. pii: jnumed.116.184655.
    PubMed     Text format    


  51. BARRIO M, Spick C, Radu CG, Lassmann M, et al
    Human biodistribution and radiation dosimetry of 18F-CFA, a PET probe targeting the deoxyribonucleoside salvage pathway.
    J Nucl Med. 2016 Nov 3. pii: jnumed.116.182394.
    PubMed     Text format     Abstract available


  52. TAGHIPOUR M, Marcus C, Sheikhbahaei S, Mena E, et al
    Clinical Indications & Impact on Management: Fourth and Subsequent Post-therapy Follow-up FDG-PET/CT Scans in Oncology Patients.
    J Nucl Med. 2016 Nov 3. pii: jnumed.116.183111.
    PubMed     Text format     Abstract available


  53. AIKAWA T, Naya M, Obara M, Manabe O, et al
    Impaired Myocardial Sympathetic Innervation is Associated with Diastolic Dysfunction in Patients with Heart Failure with Preserved Ejection Fraction: 11C-hydroxyephedrine PET Study.
    J Nucl Med. 2016 Nov 3. pii: jnumed.116.178558.
    PubMed     Text format     Abstract available


  54. BETANCUR J, Rubeaux M, Fuchs T, Otaki Y, et al
    Automatic Valve Plane Localization in Myocardial Perfusion SPECT/CT by Machine Learning: Anatomical and Clinical Validation.
    J Nucl Med. 2016 Nov 3. pii: jnumed.116.179911.
    PubMed     Text format     Abstract available


  55. KATIYAR P, Divine MR, Kohlhofer U, Quintanilla-Martinez L, et al
    Spectral Clustering predicts tumor tissue heterogeneity using dynamic 18F-FDG PET: a complement to the standard compartmental modeling approach.
    J Nucl Med. 2016 Nov 3. pii: jnumed.116.181370.
    PubMed     Text format     Abstract available


  56. SCHWARZ SW
    SNMMI Leadership Update: Quality Systems Personnel Training Program for Radiopharmaceutical Manufacturing.
    J Nucl Med. 2016;57:22N.
    PubMed     Text format    


    October 2016
  57. KHANAPUR S, Waarde AV, Dierckx RA, Elsinga PH, et al
    Preclinical Evaluation and Quantification of 18F-Fluoroethyl and 18F-Fluoropropyl analogs of SCH442416 as Radioligands for PET Imaging of the Adenosine A2A Receptors in Rat Brain.
    J Nucl Med. 2016 Oct 27. pii: jnumed.116.178103.
    PubMed     Text format     Abstract available


  58. HYAFIL F, Pelisek J, Laitinen I, Schottelius M, et al
    Imaging the cytokine receptor CXCR4 in atherosclerotic plaques with the radiotracer 68Ga-pentixafor for positron emission tomography.
    J Nucl Med. 2016 Oct 27. pii: jnumed.116.179663.
    PubMed     Text format     Abstract available


  59. HUANG CC, Wu CH, Huang YY, Tzen KY, et al
    Performing Repeated Quantitative Small Animal PET Studies with Arterial Input Functions is Routinely-Feasible in Rats.
    J Nucl Med. 2016 Oct 27. pii: jnumed.116.182402.
    PubMed     Text format     Abstract available


  60. NA SJ, Oh JK, Hyun SH, Lee JW, et al
    18F-FDG PET/CT can predict survival of advanced hepatocellular carcinoma patients: A multicenter retrospective cohort study.
    J Nucl Med. 2016 Oct 27. pii: jnumed.116.182022.
    PubMed     Text format     Abstract available


  61. VAN DER GUCHT A, Aoun Sebaiti M, Guedj E, Aouizerate J, et al
    Brain FDG-PET metabolic abnormalities in patients with long-lasting macrophagic myofasciitis.
    J Nucl Med. 2016 Oct 20. pii: jnumed.114.151878.
    PubMed     Text format     Abstract available


  62. VALTORTA S, Moro M, Prisinzano G, Bertolini G, et al
    Metabolic evaluation of non-small cell lung cancer patient-derived xenografts models using [18F]FDG PET: potential tools for early therapy response.
    J Nucl Med. 2016 Oct 20. pii: jnumed.116.176404.
    PubMed     Text format     Abstract available


  63. MICHELHAUGH SK, Muzik O, Guastella AR, Klinger NV, et al
    Assessment of tryptophan uptake and kinetics using 1-(2-[18F]fluoroethyl)-L-tryptophan and alpha-[11C]-methyl-L-tryptophan PET imaging in mice implanted with patient-derived brain tumor xenografts.
    J Nucl Med. 2016 Oct 20. pii: jnumed.116.179994.
    PubMed     Text format     Abstract available


  64. DESSEROIT MC, Tixier F, Weber WA, Siegel BA, et al
    Reliability of PET/CT shape and heterogeneity features in functional and morphological components of Non-Small Cell Lung Cancer tumors: a repeatability analysis in a prospective multi-center cohort.
    J Nucl Med. 2016 Oct 20. pii: jnumed.116.180919.
    PubMed     Text format     Abstract available


  65. JANSEN M, Veldhuijzen van Zanten SE, Van Vuurden DG, Huisman M, et al
    Molecular Drug Imaging: 89Zr-bevacizumab PET in Children with Diffuse Intrinsic Pontine Glioma.
    J Nucl Med. 2016 Oct 20. pii: jnumed.116.180216.
    PubMed     Text format     Abstract available


  66. BEUKINGA J, Hulshoff JB, Dijk LV, Muijs C, et al
    Predicting response to neoadjuvant chemoradiotherapy in esophageal cancer with textural features derived from pre-treatment 18F-FDG PET/CT imaging.
    J Nucl Med. 2016 Oct 13. pii: jnumed.116.180299.
    PubMed     Text format     Abstract available


  67. BAUER M, Karch R, Tournier N, Cisternino S, et al
    Assessment of P-glycoprotein Transport Activity at the Human Blood-Retinal Barrier with (R)-11C-verapamil PET.
    J Nucl Med. 2016 Oct 13. pii: jnumed.116.182147.
    PubMed     Text format     Abstract available


  68. FAYAD H, Schmidt H, Kuestner T, Visvikis D, et al
    4D MR and attenuation map generation in PET/MR imaging using 4D PET derived deformation matrices: a feasibility study for lung cancer applications.
    J Nucl Med. 2016 Oct 13. pii: jnumed.116.178947.
    PubMed     Text format     Abstract available


  69. SPETH SC, Kruitwagen RF, Kleppe M, Pooters IN, et al
    Comparison of intra-operative gamma probe detection with postoperative SPECT/CT of sentinel nodes related to the ovary.
    J Nucl Med. 2016 Oct 13. pii: jnumed.116.183426.
    PubMed     Text format     Abstract available


  70. ORLHAC F, Nioche C, Soussan M, Buvat I, et al
    Understanding changes in tumor textural indices in PET: a comparison between visual assessment and index values in simulated and patient data.
    J Nucl Med. 2016 Oct 6. pii: jnumed.116.181859.
    PubMed     Text format     Abstract available


  71. UNTERRAINER M, Galldiks N, Suchorska B, Kowalew LC, et al
    18F-FET PET uptake characteristics in patients with newly diagnosed and untreated brain metastasis.
    J Nucl Med. 2016 Oct 6. pii: jnumed.116.180075.
    PubMed     Text format     Abstract available


  72. BAKHSHI S, Bhethanabhotla S, Kumar R, Agarwal K, et al
    Post-treatment PET-CT Rather than Interim PET-CT Using Deauville criteria Predicts Outcome in Pediatric Hodgkin Lymphoma: a Prospective Study Comparing PET-CT versus Conventional Imaging.
    J Nucl Med. 2016 Oct 6. pii: jnumed.116.176511.
    PubMed     Text format     Abstract available


  73. GUO T, Brendel M, Grimmer T, Rominger A, et al
    Predicting regional pattern of longitudinal beta-amyloid accumulation by baseline positron emission tomography.
    J Nucl Med. 2016 Oct 6. pii: jnumed.116.176115.
    PubMed     Text format     Abstract available


  74. ROWE SP, Drzezga A, Neumaier B, Dietlein M, et al
    Prostate-Specific Membrane Antigen-Targeted Radiohalogenated PET and Therapeutic Agents for Prostate Cancer.
    J Nucl Med. 2016;57.
    PubMed     Text format     Abstract available


  75. MANSI R, Minamimoto R, Macke H, Iagaru AH, et al
    Bombesin-Targeted PET of Prostate Cancer.
    J Nucl Med. 2016;57.
    PubMed     Text format     Abstract available


  76. BEHESHTI M, Rezaee A, Geinitz H, Loidl W, et al
    Evaluation of Prostate Cancer Bone Metastases with 18F-NaF and 18F-Fluorocholine PET/CT.
    J Nucl Med. 2016;57.
    PubMed     Text format     Abstract available


  77. CECI F, Castellucci P, Mapelli P, Incerti E, et al
    Evaluation of Prostate Cancer with 11C-Choline PET/CT for Treatment Planning, Response Assessment, and Prognosis.
    J Nucl Med. 2016;57.
    PubMed     Text format     Abstract available


  78. MAPELLI P, Incerti E, Ceci F, Castellucci P, et al
    11C- or 18F-Choline PET/CT for Imaging Evaluation of Biochemical Recurrence of Prostate Cancer.
    J Nucl Med. 2016;57.
    PubMed     Text format     Abstract available


  79. NITSCH S, Hakenberg OW, Heuschkel M, Drager D, et al
    Evaluation of Prostate Cancer with 11C- and 18F-Choline PET/CT: Diagnosis and Initial Staging.
    J Nucl Med. 2016;57.
    PubMed     Text format     Abstract available


  80. SPICK C, Herrmann K, Czernin J
    Evaluation of Prostate Cancer with 11C-Acetate PET/CT.
    J Nucl Med. 2016;57.
    PubMed     Text format     Abstract available


  81. JADVAR H
    PET of Glucose Metabolism and Cellular Proliferation in Prostate Cancer.
    J Nucl Med. 2016;57.
    PubMed     Text format     Abstract available


  82. LINDENBERG L, Ahlman M, Turkbey B, Mena E, et al
    Evaluation of Prostate Cancer with PET/MRI.
    J Nucl Med. 2016;57.
    PubMed     Text format     Abstract available


    September 2016
  83. SCHAEFFERKOETTER JD, Yan J, Soderlund TA, Townsend DW, et al
    Quantitative Accuracy and Lesion Detectability of Low-Dose FDG-PET for Lung Cancer Screening.
    J Nucl Med. 2016 Sep 29. pii: jnumed.116.177592.
    PubMed     Text format     Abstract available


  84. WHITWELL J, Graff-Radford J, Singh T, Drubach D, et al
    18F-FDG PET in Posterior Cortical Atrophy and Dementia with Lewy Bodies.
    J Nucl Med. 2016 Sep 29. pii: jnumed.116.179903.
    PubMed     Text format     Abstract available


  85. ROWLEY LM N/A, Bradley KM, Boardman P, Hallam A, et al
    Optimization of image reconstruction for yttrium-90 SIRT on a LYSO PET/CT system using a Bayesian penalized likelihood reconstruction algorithm.
    J Nucl Med. 2016 Sep 29. pii: jnumed.116.176552.
    PubMed     Text format     Abstract available


  86. CHAE SY, Kim SB, Ahn SH, Kim HO, et al
    A randomized feasibility study of 18F-fluoroestradiol positron emission tomography to predict pathological response to neoadjuvant systemic therapy in estrogen receptor-rich postmenopausal breast cancer.
    J Nucl Med. 2016 Sep 29. pii: jnumed.116.178368.
    PubMed     Text format     Abstract available


  87. LODGE MA, Holdhoff M, Leal JP, Bag AK, et al
    Repeatability of 18F-FLT PET in a Multi-Center Study of Patients with High Grade Glioma.
    J Nucl Med. 2016 Sep 29. pii: jnumed.116.178434.
    PubMed     Text format     Abstract available


  88. AHN SS, Hwang SH, Jung SM, Lee SW, et al
    Evaluation of spleen glucose metabolism in patients with febrile autoimmune diseases using 18F-FDG PET/CT.
    J Nucl Med. 2016 Sep 29. pii: jnumed.116.180729.
    PubMed     Text format     Abstract available


  89. ZUKOTYNSKI K, Jadvar H, Hope TA, Subramaniam RM, et al
    SNMMI Comment on the 2016 Society of Surgical Oncology "Choosing Wisely" Recommendation on the Use of PET/CT in Colorectal Cancer.
    J Nucl Med. 2016 Sep 29. pii: jnumed.116.182584.
    PubMed     Text format    


  90. AHMADZADEHFAR H, Azgomi K, Hauser S, Wei X, et al
    68Ga-PSMA-11 PET as a gate-keeper for the treatment of metastatic prostate cancer with radium-223: proof of concept.
    J Nucl Med. 2016 Sep 22. pii: jnumed.116.178533.
    PubMed     Text format     Abstract available


  91. JOHNBECK CB, Knigge U, Loft A, Berthelsen AK, et al
    Head-to-head comparison of 64Cu-DOTATATE and 68Ga-DOTATOC PET/CT: a prospective study of 59 patients with neuroendocrine tumors.
    J Nucl Med. 2016 Sep 22. pii: jnumed.116.180430.
    PubMed     Text format     Abstract available


  92. GARG PK, Lokitz SJ, Nazih R, Garg S, et al
    Biodistribution and Radiation Dosimetry of C-11 Nicotine from Whole Body PET Imaging in Humans.
    J Nucl Med. 2016 Sep 22. pii: jnumed.116.180059.
    PubMed     Text format     Abstract available


  93. WOOTEN D, Guehl NJ, Verwer EE, Shoup TM, et al
    Pharmacokinetic evaluation of the tau PET radiotracer [18F]T807 ([18F]AV-1451) in human subjects.
    J Nucl Med. 2016 Sep 22. pii: jnumed.115.170910.
    PubMed     Text format     Abstract available


  94. PALESTRO CJ
    Reply: Opinion on favoring labeled leukocyte imaging over 18F-FDG-PET for diagnosing prosthetic joint infection: Rectifying ongoing misconceptions.
    J Nucl Med. 2016 Sep 22. pii: jnumed.116.181669.
    PubMed     Text format    


  95. MANSOR MS, Yaqub M, Boellaard R, Froklage FE, et al
    Parametric methods for dynamic 11C-Phenytoin PET studies.
    J Nucl Med. 2016 Sep 22. pii: jnumed.116.178707.
    PubMed     Text format     Abstract available


  96. GIESEL F, Schneider F, Kratochwil C, Rath D, et al
    CT radiomic analysis using lymph-node-density profile in correlation to SUV-value for PET/CT based N-Staging.
    J Nucl Med. 2016 Sep 22. pii: jnumed.116.179648.
    PubMed     Text format     Abstract available


  97. HOPE TA, Truillet CC, Ehman EC, Afshar-Oromieh A, et al
    Imaging Response to Androgen Receptor Inhibition Using 68Ga-PSMA-11 PET: First Human Experience.
    J Nucl Med. 2016 Sep 22. pii: jnumed.116.181800.
    PubMed     Text format     Abstract available


  98. HU Z, Zhao M, Qu Y, Zhang X, et al
    In vivo three-dimensional radiopharmaceutical excited fluorescence tomography.
    J Nucl Med. 2016 Sep 22. pii: jnumed.116.180596.
    PubMed     Text format     Abstract available


  99. ROBU S, Schottelius M, Eiber M, Maurer T, et al
    Preclinical evaluation and first patient application of 99mTc-PSMA-I&S for SPECT imaging and radioguided surgery in prostate cancer.
    J Nucl Med. 2016 Sep 15. pii: jnumed.116.178939.
    PubMed     Text format     Abstract available


  100. JANI A, Schreibmann E, Rossi PJ, Shelton JW, et al
    Impact of Fluciclovine (18F) Positron Emission Tomography on Target Volume Definition for Post-Prostatectomy Salvage Radiotherapy: Initial Findings from a Randomized Trial.
    J Nucl Med. 2016 Sep 8. pii: jnumed.116.176057.
    PubMed     Text format     Abstract available


  101. KASTE SC, Snyder SE, Metzger ML, Sandlund JT, et al
    Comparison of 11C-methionine and 18F-FDG PET-CT for staging and follow-up of pediatric lymphoma.
    J Nucl Med. 2016 Sep 8. pii: jnumed.116.178640.
    PubMed     Text format     Abstract available


  102. RASMUSSEN JH, Norgaard M, Hansen AE, Vogelius IR, et al
    Feasibility of Multiparametric Imaging with PET/MR in Head and Neck Squamous Cell Carcinoma.
    J Nucl Med. 2016 Sep 8. pii: jnumed.116.180091.
    PubMed     Text format     Abstract available


  103. SKOVGAARD D, Persson M, Brandt-Larsen M, Christensen C, et al
    Safety, dosimetry and tumor detection ability of 68Ga-NOTA-AE105 - a novel radioligand for uPAR PET imaging: first-in-humans study.
    J Nucl Med. 2016 Sep 8. pii: jnumed.116.178970.
    PubMed     Text format     Abstract available


  104. GARRIGUE P, Hache G, Bennis Y, Brige P, et al
    EPO pretreatment of ECFCs enhances functional recovery after transplantation in a rat model of cerebral ischemia through an increase of their homing abilities: a SPECT/CT study.
    J Nucl Med. 2016 Sep 8. pii: jnumed.115.170308.
    PubMed     Text format     Abstract available


  105. JADVAR H
    Pathways to the Future of Nuclear Medicine Task Force: Phase 1 Report.
    J Nucl Med. 2016;57:17N-9N.
    PubMed     Text format    


  106. GORDON L, Lapi SE, Anderson C, Schwarz SW, et al
    Working Together to Advance Women in Nuclear Medicine.
    J Nucl Med. 2016;57:14N.
    PubMed     Text format    


  107. LEBON V, Alberini JL, Pierga JY, Dieras V, et al
    The rate of distant metastases on FDG-PET/CT at initial staging of breast cancer: comparison between women younger and older than 40 years.
    J Nucl Med. 2016 Sep 1. pii: jnumed.116.178749.
    PubMed     Text format     Abstract available


  108. SHRESTHA S, Liow JS, Zoghbi S, Ikawa M, et al
    The 5-HT1A receptor PET radioligand 11C-CUMI-101 has significant binding to alpha1 adrenoceptors in human cerebellum, limiting its use as a reference region.
    J Nucl Med. 2016 Sep 1. pii: jnumed.116.174151.
    PubMed     Text format     Abstract available


    August 2016
  109. DIMBER R, Guo Q, Bishop C, Adonis A, et al
    Evidence of brain inflammation in patients with Human T Lymphotropic Virus type 1 associated myelopathy (HAM): A pilot multi modal imaging study using [11C] PBR28 PET, MR T1w and DWI.
    J Nucl Med. 2016 Aug 25. pii: jnumed.116.175083.
    PubMed     Text format     Abstract available


  110. BATEMAN T, Dilsizian V, Beanlands R, DePuey EG, et al
    ASNC/SNMMI Position Statement on the Clinical Indications for Myocardial Perfusion PET.
    J Nucl Med. 2016 Aug 25. pii: jnumed.116.180448.
    PubMed     Text format    


  111. D'SOUZA JW, Hensley H, Doss M, Beigarten C, et al
    Cerenkov Luminescence Imaging as a Modality to Evaluate Antibody-based Positron Emission Tomography Radiotracers.
    J Nucl Med. 2016 Aug 18. pii: jnumed.116.178780.
    PubMed     Text format     Abstract available


  112. RENAUD JM, Yip K, Guimond J, Trottier M, et al
    Characterization of 3D PET systems for accurate quantification of myocardial blood flow.
    J Nucl Med. 2016 Aug 18. pii: jnumed.116.174565.
    PubMed     Text format     Abstract available


  113. KHOSHNEVISAN A, Chuamsaamarkkee K, Boudjemeline M, Jackson A, et al
    18F-Fluorosulfate for PET imaging of the sodium/iodide symporter: synthesis and biological evaluation in vitro and in vivo.
    J Nucl Med. 2016 Aug 18. pii: jnumed.116.177519.
    PubMed     Text format     Abstract available


  114. FENDLER WP, Barrio M, Spick C, Allen-Auerbach M, et al
    68Ga-DOTATATE PET/CT interobserver agreement for neuroendocrine tumor assessments: results from a prospective study on 50 patients.
    J Nucl Med. 2016 Aug 18. pii: jnumed.116.179192.
    PubMed     Text format     Abstract available


  115. DE BOER P, Piet AH, Oprea-Lager DE, Slotman B, et al
    Letter: PET-guided stereotactic irradiation of prostate cancer lymph node metastases.
    J Nucl Med. 2016 Aug 18. pii: jnumed.116.181149.
    PubMed     Text format    


  116. WONG KK, Raffel DM, Bohnen NI, Altinok G, et al
    2-Year Natural Decline of Cardiac Sympathetic Innervation in Idiopathic Parkinson Disease Studied with 11C-Hydroxyephedrine (HED) PET.
    J Nucl Med. 2016 Aug 18. pii: jnumed.116.176891.
    PubMed     Text format     Abstract available


  117. FENDLER WP, Czernin J, Herrmann K, Beyer T, et al
    Variations in PET/MRI operations: Results from an international survey among 39 active sites.
    J Nucl Med. 2016 Aug 11. pii: jnumed.116.174169.
    PubMed     Text format     Abstract available


  118. PANAGIOTIDIS E, Alshammari A, Michopoulou S, Skoura E, et al
    Comparison of the impact of 68Ga-DOTATATE and 18F-FDG PET/CT on clinical management in patients with neuroendocrine tumors.
    J Nucl Med. 2016 Aug 11. pii: jnumed.116.178095.
    PubMed     Text format     Abstract available


  119. KWEE TC, Basu S, Alavi A
    Letter: Opinion on favoring labeled leukocyte imaging over 18F-FDG-PET for diagnosing prosthetic joint infection: Rectifying ongoing misconceptions.
    J Nucl Med. 2016 Aug 11. pii: jnumed.116.181461.
    PubMed     Text format    


  120. TOURNIER N, Goutal S, Auvity S, Traxl A, et al
    Strategies to inhibit ABCB1- and ABCG2-mediated efflux transport of erlotinib at the blood-brain barrier: a PET study in non-human primates.
    J Nucl Med. 2016 Aug 4. pii: jnumed.116.178665.
    PubMed     Text format     Abstract available


  121. ZHANG J, Niu G, Lang L, Li F, et al
    Clinical translation of a dual integrin alphavbeta3 and GRPR targeting PET radiotracer 68Ga-NOTA-BBN-RGD.
    J Nucl Med. 2016 Aug 4. pii: jnumed.116.177048.
    PubMed     Text format     Abstract available


  122. TAIEB D, Patronas NJ, Pacak K
    Reply: [68Ga]-DOTATATE PET/CT versus MRI: why the comparison of [68Ga]-DOTATATE PET/CT to an appropriate MRI protocol is essential.
    J Nucl Med. 2016 Aug 4. pii: jnumed.116.180109.
    PubMed     Text format    



  123. Foundation Opens $2-Million Competition for Alpha-Synuclein PET Tracer.
    J Nucl Med. 2016;57:10N.
    PubMed     Text format    


  124. MINOSHIMA S, Drzezga AE, Barthel H, Bohnen N, et al
    SNMMI Procedure Standard/EANM Practice Guideline for Amyloid PET Imaging of the Brain 1.0.
    J Nucl Med. 2016;57:1316-22.
    PubMed     Text format    


    July 2016
  125. LAMONICA D, Graf DA, Munteanu MC, Czuczman MS, et al
    18F-Fluorodeoxyglucose (FDG) PET for Measurement of Response and Prediction of Outcome to Relapsed/Refractory Mantle Cell Lymphoma (MCL) Therapy with Bendamustine-Rituximab(BR).
    J Nucl Med. 2016 Jul 28. pii: jnumed.116.173542.
    PubMed     Text format     Abstract available


  126. MAZERE J, Lamare F, Fernandez P, Allard M, et al
    123I-iodobenzovesamicol SPECT Imaging of Cholinergic Systems in Dementia with Lewy Bodies.
    J Nucl Med. 2016 Jul 28. pii: jnumed.116.176180.
    PubMed     Text format     Abstract available


  127. MELLHAMMAR EM, Dahlbom M, Axelsson J, Strand SE, et al
    Count rate characteristics and image distortion in preclinical PET systems during intratherapeutic radiopharmaceutical therapy imaging.
    J Nucl Med. 2016 Jul 28. pii: jnumed.116.175539.
    PubMed     Text format     Abstract available


  128. HUTTERER M, Ebner Y, Riemenschneider MJ, Willuweit A, et al
    Epileptic activity increases cerebral amino acid transport assessed by [18F]-fluoroethyl-L-tyrosine amino acid PET - a potential brain tumor mimic.
    J Nucl Med. 2016 Jul 28. pii: jnumed.116.176610.
    PubMed     Text format     Abstract available


  129. JOHNBECK CB, Knigge UP, Langer S, Jakobsen AL, et al
    Prognostic value of 18F-FLT PET in patients with neuroendocrine neoplasms: a prospective head-to-head comparison with 18F-FDG PET and Ki67 in 100 patients.
    J Nucl Med. 2016 Jul 28. pii: jnumed.116.174714.
    PubMed     Text format     Abstract available


  130. GRAVEL G, Gimenez-Roqueplo AP, Halimi P
    Letter: [68Ga]-DOTATATE PET/CT versus MRI: why the comparison of [68Ga]-DOTATATE PET/CT to an appropriate MRI protocol is essential.
    J Nucl Med. 2016 Jul 21. pii: jnumed.116.179960.
    PubMed     Text format    


  131. LIN C, Bradshaw TJ, Perk TG, Harmon S, et al
    Repeatability of Quantitative 18F-NaF PET: A Multicenter Study.
    J Nucl Med. 2016 Jul 21. pii: jnumed.116.177295.
    PubMed     Text format     Abstract available


  132. TAIEB D, Hicks RJ, Pacak K
    Nuclear medicine in cancer theranostics: beyond the target.
    J Nucl Med. 2016 Jul 21. pii: jnumed.116.178343.
    PubMed     Text format    


  133. HORTI AG, Wang Y, Minn IL, Lan X, et al
    18F-FNDP for PET Imaging of Soluble Epoxide Hydrolase (sEH).
    J Nucl Med. 2016 Jul 14. pii: jnumed.116.173245.
    PubMed     Text format     Abstract available


  134. WONG KH, Panek R, Welsh LC, Mcquaid D, et al
    The predictive value of early assessment after one cycle of induction chemotherapy with 18F-FDG-PET/CT and DW-MRI for response to radical chemoradiotherapy in head and neck squamous cell carcinoma.
    J Nucl Med. 2016 Jul 14. pii: jnumed.116.174433.
    PubMed     Text format     Abstract available


  135. HARADA N, Kimura H, Onoe S, Watanabe H, et al
    Synthesis and Biological Evaluation of Novel 18F-Labeled Probes Targeting Prostate-Specific Membrane Antigen for Positron Emission Tomography of Prostate Cancer.
    J Nucl Med. 2016 Jul 14. pii: jnumed.116.175810.
    PubMed     Text format     Abstract available


  136. MAYA Y, Werner RA, Schutz C, Wakabayashi H, et al
    11C-methionine PET of myocardial inflammation in a rat model of experimental autoimmune myocarditis.
    J Nucl Med. 2016 Jul 7. pii: jnumed.116.174045.
    PubMed     Text format     Abstract available


  137. NIE X, Laforest R, Elvington A, Randolph GJ, et al
    PET/MR imaging of hypoxic atherosclerosis using 64Cu-ATSM in a rabbit model.
    J Nucl Med. 2016 Jul 7. pii: jnumed.116.172544.
    PubMed     Text format     Abstract available


  138. SCHWARZ SW
    SNMMI Leadership Update: Working Together to Advance Nuclear Medicine and Molecular Imaging.
    J Nucl Med. 2016;57:13N.
    PubMed     Text format    


    June 2016
  139. NKOULOU R MD, Fuchs TA Md, Pazhenkottil AP Md, Kuest SM Md, et al
    Absolute Myocardial Blood Flow and Flow Reserve Assessed by Gated SPECT with Cadmium-Zinc-Telluride Detectors Using 99mTc-Tetrofosmin: Head to Head Comparison with 13N-Ammonia PET.
    J Nucl Med. 2016 Jun 30. pii: jnumed.115.165498.
    PubMed     Text format     Abstract available


  140. SEKINE T, Ter Voert EE, Warnock G, Buck A, et al
    Clinical evaluation of ZTE attenuation correction for brain FDG-PET/MR imaging-comparison with atlas attenuation correction.
    J Nucl Med. 2016 Jun 23. pii: jnumed.116.175398.
    PubMed     Text format     Abstract available


  141. KIM EJ, Kim S, Seo HS, Lee YJ, et al
    Novel PET imaging of atherosclerosis with 68Ga-labeled NOTA-Neomannosylated Human Serum Albumin.
    J Nucl Med. 2016 Jun 23. pii: jnumed.116.172650.
    PubMed     Text format     Abstract available


  142. GNESIN S, Canetti L, Adib S, Cherbuin N, et al
    Partition model based 99mTc-MAA SPECT/CT predictive dosimetry compared to 90Y TOF PET/CT post-treatment dosimetry in radioembolisation of hepatocellular carcinoma: A quantitative agreement comparison.
    J Nucl Med. 2016 Jun 15. pii: jnumed.116.173104.
    PubMed     Text format     Abstract available


  143. LIAO GJ, Clark AS, Schubert EK, Mankoff DA, et al
    18F-Fluoroestradiol PET: Current Status and Potential Future Clinical Applications.
    J Nucl Med. 2016 Jun 15. pii: jnumed.116.175596.
    PubMed     Text format     Abstract available


  144. LAW WP, Wang WY, Moore PT, Mollee PN, et al
    Cardiac amyloid imaging with 18F-florbetaben positron emission tomography: a pilot study.
    J Nucl Med. 2016 Jun 15. pii: jnumed.115.169870.
    PubMed     Text format     Abstract available


  145. LEURQUIN-STERK G, Van den Stock J, Crunelle CL, de Laat B, et al
    Positive Association Between Limbic Metabotropic Glutamate Receptor 5 Availability and Novelty-Seeking Temperament in Humans: a 18F-FPEB PET study.
    J Nucl Med. 2016 Jun 9. pii: jnumed.116.176032.
    PubMed     Text format     Abstract available


  146. ZHOU M, Melancon M, Stafford RJ, Li J, et al
    Precision Nanomedicine Using Dual Positron Emission Tomography and Magnetic Resonance Temperature Imaging-Guided Photothermal Therapy.
    J Nucl Med. 2016 Jun 9. pii: jnumed.116.172775.
    PubMed     Text format     Abstract available


  147. GROOTJANS W, Tixier F, van der Vos CS, Vriens D, et al
    The impact of optimal respiratory gating and image noise on evaluation of intra-tumor heterogeneity in 18F-FDG positron emission tomography imaging of lung cancer.
    J Nucl Med. 2016 Jun 9. pii: jnumed.116.173112.
    PubMed     Text format     Abstract available


  148. QUAK E, Le Roux PY, Lasnon C, Robin P, et al
    Does PET SUV harmonization impact PERCIST response classification?
    J Nucl Med. 2016 Jun 9. pii: jnumed.115.171983.
    PubMed     Text format     Abstract available


  149. RAUSCHER I, Maurer T, Beer AJ, Graner FP, et al
    Value of 68Ga-PSMA HBED-CC PET for the assessment of lymph node metastases in prostate cancer patients with biochemical recurrence: comparison with histopathology after salvage lymphadenectomy.
    J Nucl Med. 2016 Jun 3. pii: jnumed.116.173492.
    PubMed     Text format     Abstract available


  150. FAN Z, Calsolaro V, Atkinson RA, Femminella GD, et al
    Flutriciclamide (18F-GE180) PET: first in human PET study of novel 3rd generation in vivo marker of human translator protein.
    J Nucl Med. 2016 Jun 3. pii: jnumed.115.169078.
    PubMed     Text format     Abstract available


  151. FENDLER WP, Schmidt DF, Wenter V, Thierfelder KM, et al
    68Ga-PSMA-HBED-CC PET/CT detects location and extent of primary prostate cancer.
    J Nucl Med. 2016 Jun 3. pii: jnumed.116.172627.
    PubMed     Text format     Abstract available


  152. GOMES A, Slart RH, Sinha B, Glaudemans AW, et al
    18F-FDG-PET/CT in the diagnostic workup of infective endocarditis and related intracardiac prosthetic material: a clear message.
    J Nucl Med. 2016 Jun 3. pii: jnumed.116.176826.
    PubMed     Text format    


  153. DOOT RK
    Invited Perspective for: 18F-FDG PET derived tumor blood flow changes after one cycle of neoadjuvant chemotherapy predicts outcome in triple-negative breast cancer.
    J Nucl Med. 2016 Jun 3. pii: jnumed.116.175687.
    PubMed     Text format    


  154. ORLHAC F, Theze B, Soussan M, Boisgard R, et al
    Multi-scale texture analysis: from 18F-FDG PET images to pathological slides.
    J Nucl Med. 2016 Jun 3. pii: jnumed.116.173708.
    PubMed     Text format     Abstract available


  155. GRANADOS U, Fuster D, Pericas JM, Llopis J, et al
    DIAGNOSTIC ACCURACY OF 18F-FDG PET/CT IN INFECTIVE ENDOCARDITIS AND IMPLANTABLE CARDIAC ELECTRONIC DEVICE INFECTION: A CROSS-SECTIONAL STUDY.
    J Nucl Med. 2016 Jun 3. pii: jnumed.116.173690.
    PubMed     Text format     Abstract available


    May 2016
  156. CYSOUW MC, Kramer GM, Hoekstra OS, Frings V, et al
    Accuracy and precision of partial volume correction in oncological PET/CT studies.
    J Nucl Med. 2016 May 26. pii: jnumed.116.173831.
    PubMed     Text format     Abstract available


  157. WU Y, Yang W, Lu L, Lu Z, et al
    Prediction of CT Substitutes from MR Images Based on Local Diffeomorphic Mapping for Brain PET Attenuation Correction.
    J Nucl Med. 2016 May 26. pii: jnumed.115.163121.
    PubMed     Text format     Abstract available


  158. DERLIN T, Alchalby H, Bannas P, Laqmani A, et al
    Serial 18F-fluorodeoxyglucose positron emission tomography for monitoring treatment response after allogeneic stem cell transplantation for myelofibrosis.
    J Nucl Med. 2016 May 26. pii: jnumed.115.166348.
    PubMed     Text format     Abstract available


  159. KIESS A, Minn IL, Vaidyanathan G, Hobbs RF, et al
    (2S)-2-(3-(1-Carboxy-5-(4-[211At]astatobenzamido)pentyl)ureido)-pentanedioic acid for PSMA-Targeted alpha-Particle Radiopharmaceutical Therapy.
    J Nucl Med. 2016 May 26. pii: jnumed.116.174300.
    PubMed     Text format     Abstract available


  160. LARIMER BM, Wehrenberg-Klee E, Caraballo A, Mahmood U, et al
    Quantitative CD3 PET Imaging Predicts Tumor Growth Response to Anti-CTLA-4 Therapy.
    J Nucl Med. 2016 May 26. pii: jnumed.116.173930.
    PubMed     Text format     Abstract available


  161. BODET-MILIN C, Faivre-Chauvet A, Carlier T, Rauscher A, et al
    Immuno-PET using anti-CEA bispecific antibody and 68Ga-labeled peptide in metastatic medullary thyroid carcinoma: clinical optimization of the pretargeting parameters in a First-in Human trial.
    J Nucl Med. 2016 May 26. pii: jnumed.116.172221.
    PubMed     Text format     Abstract available


  162. HOSTETLER ED, Walji AM, Zeng Z, Miller P, et al
    Preclinical characterization of 18F-MK-6240, a promising positron emission tomography (PET) tracer for in vivo quantification of human neurofibrillary tangles (NFTs).
    J Nucl Med. 2016 May 26. pii: jnumed.115.171678.
    PubMed     Text format     Abstract available


  163. LEITHNER D, Baltzer P, Magometschnigg H, Wengert G, et al
    Quantitative Assessment of Breast Parenchymal Uptake in 18F-FDG PET/CT: Correlation with Age, Background Parenchymal Enhancement, and Amount of Fibroglandular Tissue on MRI.
    J Nucl Med. 2016 May 26. pii: jnumed.116.174904.
    PubMed     Text format     Abstract available


  164. ORY D, Celen S, Gijsbers R, Van Den Haute C, et al
    Preclinical evaluation of a P2X7 receptor selective radiotracer: PET studies in a rat model with local overexpression of the human P2X7 receptor and in non-human primates.
    J Nucl Med. 2016 May 19. pii: jnumed.115.169995.
    PubMed     Text format     Abstract available


  165. JENTZEN W, Verschure F, van Zon A, van de Kolk R, et al
    Response Assessment of Bone Metastases from Differentiated Thyroid Cancer Patients in the Initial Radioiodine Treatment Using Iodine-124 PET Imaging.
    J Nucl Med. 2016 May 19. pii: jnumed.115.170571.
    PubMed     Text format     Abstract available


  166. DILSIZIAN V
    Highlights from the Updated Joint ASNC/SNMMI PET Myocardial Perfusion and Metabolism Clinical Imaging Guidelines.
    J Nucl Med. 2016 May 19. pii: jnumed.116.176214.
    PubMed     Text format    


  167. CHEN L, Nabulsi N, Naganawa M, Zasadny K, et al
    Preclinical Evaluation of 18F-PF-05270430, a Novel PET Radioligand for the Phosphodiesterase 2A Enzyme.
    J Nucl Med. 2016 May 19. pii: jnumed.115.171454.
    PubMed     Text format     Abstract available


  168. HARALAMPIEVA D, Betzel T, Dinulovic I, Salemi S, et al
    Non-invasive Imaging and Tracking of Engineered Human Muscle Precursor Cells for Skeletal Muscle Tissue Engineering Using Positron Emission Tomography.
    J Nucl Med. 2016 May 19. pii: jnumed.115.170548.
    PubMed     Text format     Abstract available


  169. ENGLAND CG, Ehlerding EB, Cai W
    Imaging the biodistribution and performance of transplanted stem cells with PET.
    J Nucl Med. 2016 May 19. pii: jnumed.116.173963.
    PubMed     Text format    


  170. FAHNERT J, Purz S, Javers JS, Heyde CE, et al
    The use of simultaneous 18F-FDG-PET/MRI for the detection of spondylodiscitis.
    J Nucl Med. 2016 May 19. pii: jnumed.115.171561.
    PubMed     Text format     Abstract available


  171. OOSTING SF, van Asselt SJ, Brouwers AH, Bongaerts AH, et al
    89Zr-bevacizumab PET visualizes disease manifestations in patients with von Hippel-Lindau disease.
    J Nucl Med. 2016 May 12. pii: jnumed.115.167643.
    PubMed     Text format     Abstract available


  172. ULANER GA, Hyman D, Ross D, Corben A, et al
    Detection of HER2-positive metastases in patients with HER2-negative primary breast cancer using the 89Zr-DFO-trastuzumab PET/CT.
    J Nucl Med. 2016 May 5. pii: jnumed.115.172031.
    PubMed     Text format     Abstract available


  173. SHCHERBININ S, Schwarz AJ, Joshi AD, Navitsky M, et al
    Kinetics of the tau PET tracer 18F-AV-1451 (T807) in subjects with normal cognitive function, mild cognitive impairment and Alzheimer's disease.
    J Nucl Med. 2016 May 5. pii: jnumed.115.170027.
    PubMed     Text format     Abstract available


  174. NOTNI J, Steiger K, Hoffmann F, Reich D, et al
    Variation of Specific Activities of Ga-68-Aquibeprin and Ga-68-Avebetrin Enables Selective PET-Imaging of Different Expression Levels of Integrins alpha5beta1 and alphavbeta3.
    J Nucl Med. 2016 May 5. pii: jnumed.116.173948.
    PubMed     Text format     Abstract available


  175. CONVERT L, Lebel R, Gascon S, Fontaine R, et al
    Real Time Microfluidic Blood Counting System for PET and SPECT Preclinical Pharmacokinetic Studies.
    J Nucl Med. 2016 May 5. pii: jnumed.115.162768.
    PubMed     Text format     Abstract available


  176. RUHLMANN M, Jentzen W, Ruhlmann V, Pettinato C, et al
    High Level of Agreement between Pretherapeutic 124I PET and Intratherapeutic 131I Images in Detecting Iodine-positive Thyroid Cancer Metastases.
    J Nucl Med. 2016 May 5. pii: jnumed.115.169649.
    PubMed     Text format     Abstract available


    April 2016
  177. HARMS HJ, Hansson NH, Tolbod LP, Kim WY, et al
    Automatic extraction of myocardial mass and volumes using parametric images from dynamic non-gated PET.
    J Nucl Med. 2016 Apr 28. pii: jnumed.115.170613.
    PubMed     Text format     Abstract available


  178. BLAUFOX MD
    PET Measurement of Renal GFR: Is there a role in Nuclear Medicine.
    J Nucl Med. 2016 Apr 21. pii: jnumed.116.174607.
    PubMed     Text format    


  179. HUMBERT O, Riedinger JM, Vrigneaud JM, Kanoun S, et al
    18F-FDG PET derived tumor blood flow changes after one cycle of neoadjuvant chemotherapy predicts outcome in triple-negative breast cancer.
    J Nucl Med. 2016 Apr 21. pii: jnumed.116.172759.
    PubMed     Text format     Abstract available


  180. JIANG S, Pogue B
    Invited Perspective for: "Near-infrared diffuse optical imaging for early prediction of breast cancer response to neoadjuvant chemotherapy: a comparative study using FDG-PET/CT".
    J Nucl Med. 2016 Apr 21. pii: jnumed.116.174367.
    PubMed     Text format    


  181. NAGANAWA M, Waterhouse RN, Nabulsi NB, Lin SF, et al
    First in human assessment of the novel PDE2A PET radiotracer 18F-PF-05270430.
    J Nucl Med. 2016 Apr 21. pii: jnumed.115.166850.
    PubMed     Text format     Abstract available


  182. KRAMER GM, Frings V, Hoetjes N, Hoekstra OS, et al
    Repeatability of Quantitative Whole Body 18F-FDG PET/CT Uptake Measures as Function of Uptake Interval and Lesion Selection in Non-Small Cell Lung Cancer Patients.
    J Nucl Med. 2016 Apr 21. pii: jnumed.115.170225.
    PubMed     Text format     Abstract available


  183. KO GB, Yoon HS, Kim KY, Lee MS, et al
    Simultaneous multi-parametric PET/MRI with silicon photomultiplier PET and ultra-high field MRI for small animal imaging.
    J Nucl Med. 2016 Apr 14. pii: jnumed.115.170019.
    PubMed     Text format     Abstract available


  184. FREY KA, Koeppe R
    Invited Perspective for Standardized Expression of 18F-NAV4694 and 11C-PiB beta-Amyloid PET Results with the Centiloid Scale.
    J Nucl Med. 2016 Apr 14. pii: jnumed.116.173989.
    PubMed     Text format    


  185. WU J, Lin SF, Gallezot JD, Chan C, et al
    Quantitative analysis of dynamic 123I-mIBG SPECT imaging data in healthy humans with a population-based metabolite correction method.
    J Nucl Med. 2016 Apr 14. pii: jnumed.115.171710.
    PubMed     Text format     Abstract available


  186. WEHRENBERG-KLEE E, Turker NS, Heidari P, Larimer BM, et al
    Differential Receptor Tyrosine Kinase PET Imaging for Therapeutic Guidance.
    J Nucl Med. 2016 Apr 14. pii: jnumed.115.169417.
    PubMed     Text format     Abstract available


  187. TADE FI, Cohen MA, Styblo TM, Odewole OA, et al
    Anti-3-[18F] FACBC (Fluciclovine) PET-CT of Breast Cancer An Exploratory Study.
    J Nucl Med. 2016 Apr 7. pii: jnumed.115.171389.
    PubMed     Text format     Abstract available


  188. FAHEY FH, Ziniel SI, Manion D, Baker A, et al
    Administered Activities for Pediatric Nuclear Medicine Procedures and the Impact of the 2010 North American Guidelines on General Hospitals in the United States.
    J Nucl Med. 2016 Apr 7. pii: jnumed.116.172148.
    PubMed     Text format     Abstract available


  189. BRACKHAN M, Bascunana P, Postema JM, Ross TL, et al
    Serial quantitative TSPO-targeted PET reveals peak microglial activation up to two weeks after an epileptogenic brain insult.
    J Nucl Med. 2016 Apr 7. pii: jnumed.116.172494.
    PubMed     Text format     Abstract available


  190. HEISS WD
    Hybrid MR/PET Imaging in Neurology: Present Applications and Prospects for the Future.
    J Nucl Med. 2016 Apr 7. pii: jnumed.116.175208.
    PubMed     Text format    


  191. JADVAR H
    SNMMI Leadership Update: Pathways to the Future of Nuclear Medicine.
    J Nucl Med. 2016;57:15N.
    PubMed     Text format    



  192. George E. Thoma, Jr., MD: Launching JNM.
    J Nucl Med. 2016;57:12N-13N.
    PubMed     Text format    


  193. LITTLEFIELD JL, Fletcher JW
    In Memoriam: George E. Thoma, Jr., MD (1922-2016).
    J Nucl Med. 2016;57:11N.
    PubMed     Text format    


  194. PARKER JA
    Value of ABNM Certification and MOC to Diplomates and the Public.
    J Nucl Med. 2016;57:10N.
    PubMed     Text format    


  195. SOLOMON SB, Cornelis F
    Interventional Molecular Imaging.
    J Nucl Med. 2016;57:493-6.
    PubMed     Text format     Abstract available


  196. GRAHAM MM, Weber WA
    Evaluation of the Efficacy of Targeted Imaging Agents.
    J Nucl Med. 2016;57:653-9.
    PubMed     Text format     Abstract available


  197. SOODGUPTA D, Zhou H, Beaino W, Lu L, et al
    Ex Vivo and In Vivo Evaluation of Overexpressed VLA-4 in Multiple Myeloma Using LLP2A Imaging Agents.
    J Nucl Med. 2016;57:640-5.
    PubMed     Text format     Abstract available


  198. BOLKESTEIN M, de Blois E, Koelewijn SJ, Eggermont AM, et al
    Investigation of Factors Determining the Enhanced Permeability and Retention Effect in Subcutaneous Xenografts.
    J Nucl Med. 2016;57:601-7.
    PubMed     Text format     Abstract available


    March 2016
  199. BINSE I, Poeppel TD, Ruhlmann M, Ezziddin S, et al
    68Ga-DOTATOC-PET/CT in patients with iodine- and 18F-FDG-negative differentiated thyroid carcinoma and elevated serum thyroglobulin.
    J Nucl Med. 2016 Mar 31. pii: jnumed.115.171942.
    PubMed     Text format     Abstract available


  200. LEE HW, Lee HM, Choi SE, Yoo H, et al
    The Prognostic Impact of Early Change in Standardized Uptake Value of 18F-fluorodeoxy-glucose Positron Emission Tomography after Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer Patients.
    J Nucl Med. 2016 Mar 31. pii: jnumed.115.166322.
    PubMed     Text format     Abstract available


  201. FAHEY FH, Bom HH, Chiti A, Choi YY, et al
    Standardization of Administered Activities in Pediatric Nuclear Medicine Part 2: A Report of the First Nuclear Medicine Global Initiative.
    J Nucl Med. 2016 Mar 31. pii: jnumed.115.169714.
    PubMed     Text format     Abstract available


  202. UNTERRAINER M, Schweisthal F, Suchorska B, Wenter V, et al
    Serial 18F-FET PET imaging of primarily 18F-FET-negative glioma - does it make sense?
    J Nucl Med. 2016 Mar 31. pii: jnumed.115.171033.
    PubMed     Text format     Abstract available


  203. WAKABAYASHI H, Werner RA, Hayakawa N, Javadi MS, et al
    Initial Preclinical Evaluation of 18F-fluorodeoxysorbitol PET as a Novel Functional Renal Imaging Agent.
    J Nucl Med. 2016 Mar 24. pii: jnumed.116.172718.
    PubMed     Text format     Abstract available


  204. NIELSEN CH, Jeppesen TE, Kristensen LK, Jensen MM, et al
    PET Imaging of Tissue Factor in Pancreatic Cancer Using 64Cu-labeled Active Site Inhibited Factor VII.
    J Nucl Med. 2016 Mar 24. pii: jnumed.115.170266.
    PubMed     Text format     Abstract available


  205. JI T, Gao S, Liu Z, Xing H, et al
    99mTc-Glu-c(RGDyK)-bombesin SPECT Can Reduce Unnecessary Biopsy of BI-RADS Category 4 On Ultrasonography.
    J Nucl Med. 2016 Mar 24. pii: jnumed.115.168773.
    PubMed     Text format     Abstract available


  206. SEKINE T, Burgos N, Warnock G, Huellner MW, et al
    Multi atlas-based attenuation correction for brain FDG-PET imaging using a TOF-PET/MR scanner- comparison with clinical single atlas- and CT-based attenuation correction.
    J Nucl Med. 2016 Mar 24. pii: jnumed.115.169045.
    PubMed     Text format     Abstract available


  207. YANG Y, Bec J, Zhou J, Zhang M, et al
    A high resolution prototype small-animal PET scanner dedicated to mouse brain imaging.
    J Nucl Med. 2016 Mar 24. pii: jnumed.115.165886.
    PubMed     Text format     Abstract available


  208. SIBILLE L, Chambert B, Alonso S, Barrau C, et al
    Impact of the Adaptive Statistical iterative Reconstruction (ASiR) technique on radiation dose and image quality in bone SPECT/CT.
    J Nucl Med. 2016 Mar 24. pii: jnumed.115.164772.
    PubMed     Text format     Abstract available


  209. PIERT M, Montgomery J, Kunju LP, Siddiqui J, et al
    18F-choline PET/MRI: the Additional Value of PET for MRI-guided Transrectal Prostate Biopsies.
    J Nucl Med. 2016 Mar 16. pii: jnumed.115.170878.
    PubMed     Text format     Abstract available


  210. PINKER K, Riedl C, Ong L, Jochelson M, et al
    Impact of the number of lesions analyzed in metastatic breast cancer on response assessment by 18F-FDG PET/CT using PERCIST.
    J Nucl Med. 2016 Mar 16. pii: jnumed.115.166629.
    PubMed     Text format     Abstract available


  211. ZHU Y, Du R, Zhu Y, Shen Y, et al
    PET Mapping of Neurofunctional Changes in a Post-traumatic Stress Disorder Model.
    J Nucl Med. 2016 Mar 16. pii: jnumed.116.173443.
    PubMed     Text format     Abstract available


  212. KIM YI, Paeng JC, Cheon GJ, Suh KS, et al
    Prediction of Post-Transplantation Recurrence of Hepatocellular Carcinoma by Using Metabolic and Volumetric Indices of 18F-FDG PET/CT.
    J Nucl Med. 2016 Mar 16. pii: jnumed.115.170076.
    PubMed     Text format     Abstract available


  213. CHEN R, Zhou X, Liu J, Huang G, et al
    Relationship between 18F-FDG PET-CT scans and HER2 expression in gastric cancer.
    J Nucl Med. 2016 Mar 10. pii: jnumed.115.171165.
    PubMed     Text format     Abstract available


  214. TIXIER F, Vriens D, Cheze-Le Rest C, Hatt M, et al
    Comparison of tumor uptake heterogeneity characterization between static and parametric 18F-FDG PET images in Non-Small Cell Lung Cancer.
    J Nucl Med. 2016 Mar 10. pii: jnumed.115.166918.
    PubMed     Text format     Abstract available


  215. SORENSEN M, Munk OL, Oerntoft N, Frisch K, et al
    Hepatobiliary Secretion Kinetics of Conjugated Bile Acids Measured in Pigs by 11C-Cholylsarcosine PET.
    J Nucl Med. 2016 Mar 10. pii: jnumed.115.171579.
    PubMed     Text format     Abstract available


  216. HARKNESS BA, Fahey FH
    A Report on the Current State of Nuclear Medicine Physics Training: The Findings of the AAPM/SNMMI Joint Task Force.
    J Nucl Med. 2016 Mar 10. pii: jnumed.115.171355.
    PubMed     Text format    


  217. ULANER GA, Goldman D, Gonen M, Pham H, et al
    Initial results of a prospective clinical trial of 18F-Fluciclovine PET/CT in newly diagnosed invasive ductal and invasive lobular breast cancers.
    J Nucl Med. 2016 Mar 3. pii: jnumed.115.170456.
    PubMed     Text format     Abstract available


  218. UEDA S, Yoshizawa N, Shigekawa T, Takeuchi H, et al
    Near-infrared diffuse optical imaging for early prediction of breast cancer response to neoadjuvant chemotherapy: a comparative study using FDG-PET/CT.
    J Nucl Med. 2016 Mar 3. pii: jnumed.115.167320.
    PubMed     Text format     Abstract available


  219. VAN WEEHAEGHE D, Ceccarini J, Delva A, Robberecht W, et al
    Prospective Validation of 18F-FDG Brain PET Discriminant Analysis Methods in the Diagnosis of Amyotrophic Lateral Sclerosis.
    J Nucl Med. 2016 Mar 3. pii: jnumed.115.166272.
    PubMed     Text format     Abstract available


  220. O'MALLEY J
    2015 SNMMI Highlights Lecture: General Nuclear Medicine.
    J Nucl Med. 2016;57:13N-8N.
    PubMed     Text format    


  221. METRAN-NASCENTE C, Yeung I, Vines DC, Metser U, et al
    Measurement of Tumor Hypoxia in Patients with Advanced Pancreatic Cancer Based on 18F-Fluoroazomyin Arabinoside Uptake.
    J Nucl Med. 2016;57:361-6.
    PubMed     Text format     Abstract available


  222. ALTAI M, Perols A, Tsourma M, Mitran B, et al
    Feasibility of Affibody-Based Bioorthogonal Chemistry-Mediated Radionuclide Pretargeting.
    J Nucl Med. 2016;57:431-6.
    PubMed     Text format     Abstract available


  223. MARQUEZ BV, Lapi SE
    Pretargeted Immuno-PET: Overcoming Limitations of Space and Time.
    J Nucl Med. 2016;57:332-3.
    PubMed     Text format    


  224. TERRY SY, Koenders MI, Franssen GM, Nayak TK, et al
    Monitoring Therapy Response of Experimental Arthritis with Radiolabeled Tracers Targeting Fibroblasts, Macrophages, or Integrin alphavbeta3.
    J Nucl Med. 2016;57:467-72.
    PubMed     Text format     Abstract available


  225. NABI F, Kassi M, Muhyieddeen K, Chang SM, et al
    Optimizing Evaluation of Patients with Low-to-Intermediate-Risk Acute Chest Pain: A Randomized Study Comparing Stress Myocardial Perfusion Tomography Incorporating Stress-Only Imaging Versus Cardiac CT.
    J Nucl Med. 2016;57:378-84.
    PubMed     Text format     Abstract available


  226. BAHLER L, Verberne HJ, Admiraal WM, Stok WJ, et al
    Differences in Sympathetic Nervous Stimulation of Brown Adipose Tissue Between the Young and Old, and the Lean and Obese.
    J Nucl Med. 2016;57:372-7.
    PubMed     Text format     Abstract available


  227. HOUGHTON JL, Zeglis BM, Abdel-Atti D, Sawada R, et al
    Pretargeted Immuno-PET of Pancreatic Cancer: Overcoming Circulating Antigen and Internalized Antibody to Reduce Radiation Doses.
    J Nucl Med. 2016;57:453-9.
    PubMed     Text format     Abstract available


    February 2016
  228. ZHU Y, Xu K, Xu C, Zhang J, et al
    PET Mapping for Brain-Computer-Interface-Based Stimulation in a Rat Model with Intracranial Electrode Implantation in the Ventro-posterior Medial Thalamus.
    J Nucl Med. 2016 Feb 25. pii: jnumed.115.171868.
    PubMed     Text format     Abstract available


  229. SONG IH, Lee TS, Park YS, Lee JS, et al
    Immuno-PET Imaging and Radioimmunotherapy of 64Cu-/177Lu-Labeled Anti-EGFR Antibody in Esophageal Squamous Cell Carcinoma Model.
    J Nucl Med. 2016 Feb 25. pii: jnumed.115.167155.
    PubMed     Text format     Abstract available


  230. RAUSCH I, Rust P, Difranco MD, Lassen M, et al
    Reproducibility of MRI Dixon-based attenuation correction in combined PET/MR with applications for lean body mass estimation.
    J Nucl Med. 2016 Feb 25. pii: jnumed.115.168294.
    PubMed     Text format     Abstract available


  231. WIERTS R, Brans B, Havekes B, Kemerink G, et al
    Dose-response Relationship in Differentiated Thyroid Cancer Patients Undergoing Radioiodine Treatment Assessed by Means of 124I PET/CT.
    J Nucl Med. 2016 Feb 25. pii: jnumed.115.168799.
    PubMed     Text format     Abstract available


  232. YU Y, Chan C, Ma T, Liu Y, et al
    Event-by-Event Continuous Respiratory Motion Correction for Dynamic PET Imaging.
    J Nucl Med. 2016 Feb 23. pii: jnumed.115.167676.
    PubMed     Text format     Abstract available


  233. CORNELIS F, Sotirchos V, Violari E, Sofocleous C, et al
    Fluoro-deoxyglucose PET/CT is an immediate imaging biomarker of treatment success after liver metastasis ablation.
    J Nucl Med. 2016 Feb 23. pii: jnumed.115.171926.
    PubMed     Text format     Abstract available


  234. BRENDEL M, Probst F, Jaworska A, Overhoff F, et al
    Glial Activation and Glucose Metabolism in a Transgenic Amyloid Mouse Model: A Triple Tracer PET Study.
    J Nucl Med. 2016 Feb 18. pii: jnumed.115.167858.
    PubMed     Text format     Abstract available


  235. KRALL N, Pretto F, Mattarella M, Muller C, et al
    A technetium 99m-labeled ligand of carbonic anhydrase IX selectively targets renal cell carcinoma in vivo.
    J Nucl Med. 2016 Feb 18. pii: jnumed.115.170514.
    PubMed     Text format     Abstract available


  236. RODRIGUEZ-VIEITEZ E, Carter SF, Chiotis K, Saint-Aubert L, et al
    Comparison of Early-Phase 11C-Deuterium-L-Deprenyl and 11C-PiB PET for Assessing Brain Perfusion in Alzheimer's Disease.
    J Nucl Med. 2016 Feb 16. pii: jnumed.115.168732.
    PubMed     Text format     Abstract available


  237. ROWE CC, Jones G, Dore V, Pejoska S, et al
    Standardized Expression of 18F-NAV4694 and 11C-PiB beta-Amyloid PET Results with the Centiloid Scale.
    J Nucl Med. 2016 Feb 16. pii: jnumed.115.171595.
    PubMed     Text format     Abstract available


  238. LILJA JA, Thurfjell L, Sorensen J
    Visualization and Quantification of Three-Dimensional Stereotactic Surface Projections for 18F-Flutemetamol PET using variable depth.
    J Nucl Med. 2016 Feb 16. pii: jnumed.115.169169.
    PubMed     Text format     Abstract available


  239. LEE JH, Sato M, Coel MN, Lee KH, et al
    Prediction of PSA Progression in Castrate-Resistant Prostate Cancer based on Treatment-Associated Change in Tumor Burden Quantified by 18F-fluorocholine PET/CT.
    J Nucl Med. 2016 Feb 16. pii: jnumed.115.169177.
    PubMed     Text format     Abstract available


  240. TSUKADA H, Kanazawa M, Ohba H, Nishiyama S, et al
    PET Imaging of Mitochondrial Complex I with 18F-BCPP-EF in Brain of Parkinson's Disease Model Monkey.
    J Nucl Med. 2016 Feb 11. pii: jnumed.115.169615.
    PubMed     Text format     Abstract available


  241. OHRI N, Duan F, Snyder BS, Wei B, et al
    Pretreatment 18FDG-PET Textural Features in Locally Advanced Non-Small Cell Lung Cancer: Secondary Analysis of ACRIN 6668/RTOG 0235.
    J Nucl Med. 2016 Feb 11. pii: jnumed.115.166934.
    PubMed     Text format     Abstract available


  242. TIAN M
    The Pathophysiologic Basis of Nuclear Medicine.
    J Nucl Med. 2016 Feb 9. pii: jnumed.116.173815.
    PubMed     Text format    


  243. HINDIE E, Zanotti-Fregonara P, Quinto M, Morgat C, et al
    Dose Deposits from 90Y, 177Lu, 111In, and 161Tb in Micrometastases of Various Sizes: Implications for Radiopharmaceutical Therapy.
    J Nucl Med. 2016 Feb 9. pii: jnumed.115.170423.
    PubMed     Text format     Abstract available


  244. NABULSI N, Mercier J, Holden D, Carre S, et al
    Synthesis and Preclinical Evaluation of 11C-UCB-J as a PET Tracer for Imaging the Synaptic Vesicle Glycoprotein 2A in the Brain.
    J Nucl Med. 2016 Feb 4. pii: jnumed.115.168179.
    PubMed     Text format     Abstract available


  245. PALYO R, Sinusas A, Liu YH
    High-Sensitivity and High-Resolution SPECT/CT Systems Provide Substantial Dose Reduction without Compromising Quantitative Precision for Assessment of Myocardial Perfusion or Function.
    J Nucl Med. 2016 Feb 4. pii: jnumed.115.164632.
    PubMed     Text format     Abstract available


  246. WARNDERS FJ, Waaijer SJ, Pool M, Lub-de Hooge MN, et al
    Biodistribution and PET Imaging of Labeled Bispecific T Cell Engaging Antibody targeting EpCAM.
    J Nucl Med. 2016 Feb 4. pii: jnumed.115.168153.
    PubMed     Text format     Abstract available


  247. KOESTERS T, Friedman KP, Fenchel M, Zhan Y, et al
    Dixon sequence with superimposed model-based bone compartment provides highly accurate PET/MR attenuation correction of the brain.
    J Nucl Med. 2016 Feb 2. pii: jnumed.115.166967.
    PubMed     Text format     Abstract available


  248. SHEIKHBAHAEI S, Mena E, Marcus C, Wray R, et al
    18F-Fluorodeoxyglucose PET/CT: Therapy Response Assessment Interpretation (Hopkins Criteria) and Survival Outcomes in Lung Cancer Patients.
    J Nucl Med. 2016 Feb 2. pii: jnumed.115.165480.
    PubMed     Text format     Abstract available


  249. KENNY L
    The Use of Novel PET Tracers to Image Breast Cancer Biologic Processes Such as Proliferation, DNA Damage and Repair, and Angiogenesis.
    J Nucl Med. 2016;57 Suppl 1:89S-95S.
    PubMed     Text format     Abstract available


  250. WAHL RL
    Quo Vadis: PET and Single-Photon Molecular Breast Imaging.
    J Nucl Med. 2016;57 Suppl 1:3S-8S.
    PubMed     Text format    


  251. AVRIL S, Muzic RF Jr, Plecha D, Traughber BJ, et al
    18F-FDG PET/CT for Monitoring of Treatment Response in Breast Cancer.
    J Nucl Med. 2016;57 Suppl 1:34S-9S.
    PubMed     Text format     Abstract available


  252. GROHEUX D, Cochet A, Humbert O, Alberini JL, et al
    18F-FDG PET/CT for Staging and Restaging of Breast Cancer.
    J Nucl Med. 2016;57 Suppl 1:17S-26S.
    PubMed     Text format     Abstract available


  253. VAN ES SC, Venema CM, Glaudemans AW, Lub-de Hooge MN, et al
    Translation of New Molecular Imaging Approaches to the Clinical Setting: Bridging the Gap to Implementation.
    J Nucl Med. 2016;57 Suppl 1:96S-104S.
    PubMed     Text format     Abstract available


  254. FOWLER AM, Clark AS, Katzenellenbogen JA, Linden HM, et al
    Imaging Diagnostic and Therapeutic Targets: Steroid Receptors in Breast Cancer.
    J Nucl Med. 2016;57 Suppl 1:75S-80S.
    PubMed     Text format     Abstract available


  255. MCDONALD ES, Mankoff DA, Mach RH
    Novel Strategies for Breast Cancer Imaging: New Imaging Agents to Guide Treatment.
    J Nucl Med. 2016;57 Suppl 1:69S-74S.
    PubMed     Text format     Abstract available


  256. ULANER GA, Riedl CC, Dickler MN, Jhaveri K, et al
    Molecular Imaging of Biomarkers in Breast Cancer.
    J Nucl Med. 2016;57 Suppl 1:53S-9S.
    PubMed     Text format     Abstract available


  257. BERG WA
    Nuclear Breast Imaging: Clinical Results and Future Directions.
    J Nucl Med. 2016;57 Suppl 1:46S-52S.
    PubMed     Text format     Abstract available


  258. COOK GJ, Azad GK, Goh V
    Imaging Bone Metastases in Breast Cancer: Staging and Response Assessment.
    J Nucl Med. 2016;57 Suppl 1:27S-33S.
    PubMed     Text format     Abstract available


  259. CZERNIN J, Mankoff D
    Introduction and Overview.
    J Nucl Med. 2016;57 Suppl 1:1S-2S.
    PubMed     Text format    


  260. PAPPAS V
    SNMMI Leadership Update: Clinical Trials Network Update.
    J Nucl Med. 2016;57:13N.
    PubMed     Text format    


  261. SEGALL GM
    Looking to the Future: The ABNM in the Next 10 Years.
    J Nucl Med. 2016;57:12N.
    PubMed     Text format    


  262. KRONAUGE J, Packard AB
    In Memoriam: Alan Davison, PhD, 1936-2015.
    J Nucl Med. 2016;57:11N-5N.
    PubMed     Text format    


  263. KOO P
    2015 Kocemba-Slosky Fellowship.
    J Nucl Med. 2016;57:10N.
    PubMed     Text format    


  264. GRADY E
    Gastrointestinal Bleeding Scintigraphy in the Early 21st Century.
    J Nucl Med. 2016;57:252-9.
    PubMed     Text format     Abstract available


  265. TAKAGI G, Miyamoto M, Fukushima Y, Yasutake M, et al
    Imaging Angiogenesis Using 99mTc-Macroaggregated Albumin Scintigraphy in Patients with Peripheral Artery Disease.
    J Nucl Med. 2016;57:192-7.
    PubMed     Text format     Abstract available


  266. GAO L, Liu H, Sun X, Gao D, et al
    Molecular Imaging of Post-Src Inhibition Tumor Signatures for Guiding Dasatinib Combination Therapy.
    J Nucl Med. 2016;57:321-6.
    PubMed     Text format     Abstract available


    January 2016
  267. LIU D DR, Khong PL, Gao Y, Mahmood U, et al
    Radiation Dosimetry of Whole-Body Dual Tracer 18F-FDG and 11C-Acetate PET/CT for Hepatocellular Carcinoma.
    J Nucl Med. 2016 Jan 28. pii: jnumed.115.165944.
    PubMed     Text format     Abstract available


  268. BURGER IA, Casanova R, Steiger S, Husmann L, et al
    FDG-PET/CT of non-small cell lung carcinoma under neo-adjuvant chemotherapy: background based adaptive volume metrics outperform TLG and MTV in predicting histopathological response.
    J Nucl Med. 2016 Jan 28. pii: jnumed.115.167684.
    PubMed     Text format     Abstract available


  269. TEUHO J, Johansson J, Liden J, Hansen AE, et al
    Effect of attenuation correction to regional quantification between PET/MR and PET/CT: a multi-centre study using a three-dimensional brain phantom.
    J Nucl Med. 2016 Jan 28. pii: jnumed.115.166165.
    PubMed     Text format     Abstract available


  270. BOLLINENI VR, Ytre-Hauge S, Bollineni-Balabay O, Salvesen H, et al
    High diagnostic value of FDG-PET/CT in endometrial cancer: Systematic review and meta-analysis of the literature.
    J Nucl Med. 2016 Jan 28. pii: jnumed.115.170597.
    PubMed     Text format     Abstract available


  271. SU Y, Rubin B, McConathy J, Laforest R, et al
    Impact of MR based attenuation correction on neurological PET studies.
    J Nucl Med. 2016 Jan 28. pii: jnumed.115.164822.
    PubMed     Text format     Abstract available


  272. SEIBYL J, Catafau AM, Barthel H, Ishii K, et al
    Impact of training method on the robustness of the visual assessment of 18F-florbetaben PET scans: results from a Phase 3 trial.
    J Nucl Med. 2016 Jan 28. pii: jnumed.115.161927.
    PubMed     Text format     Abstract available


  273. APOLO AB, Lindenberg L, Shih JH, Mena E, et al
    Prospective Study Evaluating Na18F-Positron Emission Tomography/Computed Tomography (NaF-PET/CT) in Predicting Clinical Outcomes and Survival in Advanced Prostate Cancer.
    J Nucl Med. 2016 Jan 21. pii: jnumed.115.166512.
    PubMed     Text format     Abstract available


  274. LUO Y, Pan Q, Shao Y, Yu M, et al
    Glucagon-like Peptide-1 Receptor PET/CT with 68Ga-NOTA-exendin-4 for Detecting Localized Insulinoma: a Prospective Cohort Study.
    J Nucl Med. 2016 Jan 21. pii: jnumed.115.167445.
    PubMed     Text format     Abstract available


  275. JONASSON M, Wall A, Chiotis K, Saint-Aubert L, et al
    Tracer kinetic analysis of (S)-18F-THK5117 as a PET tracer for assessing tau pathology.
    J Nucl Med. 2016 Jan 21. pii: jnumed.115.158519.
    PubMed     Text format     Abstract available


  276. O JH, Luber BS, Leal JP, Wang H, et al
    Response to early treatment evaluated with 18F-FDG PET and PERCIST 1.0 predicts survival in patients with Ewing sarcoma family of tumors treated with a monoclonal antibody to the insulin-like growth factor 1 receptor.
    J Nucl Med. 2016 Jan 21. pii: jnumed.115.162412.
    PubMed     Text format     Abstract available


  277. VAN ROSSUM PS, Fried DV, Zhang L, Hofstetter WL, et al
    The incremental value of subjective and quantitative assessment of 18F-FDG PET for the prediction of pathologic complete response to preoperative chemoradiotherapy in esophageal cancer.
    J Nucl Med. 2016 Jan 21. pii: jnumed.115.163766.
    PubMed     Text format     Abstract available


  278. LUEHMANN HP, Detering L, Fors BP, Pressly ED, et al
    PET/CT Imaging of Chemokine Receptors in Inflammatory Atherosclerosis Using Targeted Nanoparticles.
    J Nucl Med. 2016 Jan 21. pii: jnumed.115.166751.
    PubMed     Text format     Abstract available


  279. VAG T, Gerngross C, Herhaus P, Eiber M, et al
    First Experience on Chemokine Receptor CXCR4 Targeted Positron Emission Tomography (PET) Imaging in Patients with Solid Cancers.
    J Nucl Med. 2016 Jan 14. pii: jnumed.115.161034.
    PubMed     Text format     Abstract available


  280. DEPPEN SA, Liu E, Blume JD, Clanton J, et al
    Safety and Efficacy of 68Ga-DOTATATE PET/CT for Diagnosis, Staging and Treatment Management of Neuroendocrine Tumors.
    J Nucl Med. 2016 Jan 14. pii: jnumed.115.163865.
    PubMed     Text format     Abstract available


  281. VILCHE MB, Reyes AL, Vasilskis E, Oliver P, et al
    68Ga-NOTA-UBI 29-41 as a PET tracer for detection of bacterial infection.
    J Nucl Med. 2016 Jan 14. pii: jnumed.115.161265.
    PubMed     Text format     Abstract available


  282. JAKOBSEN S, Busk M, Jensen JB, Munk OL, et al
    A PET Tracer For Renal Organic Cation Transporters, 11C-metformin: Radiosynthesis and Preclinical Proof-of-Concept Studies.
    J Nucl Med. 2016 Jan 14. pii: jnumed.115.169292.
    PubMed     Text format     Abstract available


  283. SAWICKI LM, Grueneisen J, Buchbender C, Schaarschmidt BM, et al
    Comparative performance of 18F-FDG PET/MRI and 18F-FDG PET/CT regarding detection and characterization of pulmonary lesions in 121 oncologic patients.
    J Nucl Med. 2016 Jan 7. pii: jnumed.115.167486.
    PubMed     Text format     Abstract available


  284. KIM EE
    Nuclear Medicine and PET/CT Cases.
    J Nucl Med. 2016 Jan 7. pii: jnumed.116.172114.
    PubMed     Text format    


  285. SPICK C, Herrmann K, Czernin J
    18F-FDG PET/CT and PET/MRI perform equally well in cancer patients: Evidence from studies in more than 2300 patients.
    J Nucl Med. 2016 Jan 7. pii: jnumed.115.158808.
    PubMed     Text format     Abstract available


  286. FENDLER WP, Lechner H, Todica A, Paprottka KJ, et al
    Safety, efficacy and prognostic factors after radioembolization of hepatic metastases from breast cancer: A large single center experience in 81 patients.
    J Nucl Med. 2016 Jan 7. pii: jnumed.115.165050.
    PubMed     Text format     Abstract available


  287. JADVAR H
    SNMMI Leadership Update: The Future of Nuclear Medicine.
    J Nucl Med. 2016;57:13N.
    PubMed     Text format    


  288. WALKER M, Ehrlichmann W, Stahlschmidt A, Pichler BJ, et al
    In Vivo Evaluation of 11C-DASB for Quantitative SERT Imaging in Rats and Mice.
    J Nucl Med. 2016;57:115-21.
    PubMed     Text format     Abstract available


  289. TRIPATHI M, Tang CC, Feigin A, De Lucia I, et al
    Automated Differential Diagnosis of Early Parkinsonism Using Metabolic Brain Networks: A Validation Study.
    J Nucl Med. 2016;57:60-6.
    PubMed     Text format     Abstract available


  290. LARSON SM
    EXINI Quantitative Bone Scan Index: Expanded Utility for the Planar Radionuclide Bone Scan.
    J Nucl Med. 2016;57:5-6.
    PubMed     Text format    


  291. URBAIN JL
    Coagulation Factor and Theranostics: A New Paradigm in Molecular Imaging.
    J Nucl Med. 2016;57:7-8.
    PubMed     Text format    


    December 2015
  292. DECAZES P, Metivier D, Rouquette A, Talbot JN, et al
    A method to improve the semi-quantification of 18F-fluorodeoxyglucose uptake : reliability of the estimated lean body mass using a limited field of acquisition, low dose CT from PET/CT.
    J Nucl Med. 2015 Dec 30. pii: jnumed.115.164913.
    PubMed     Text format     Abstract available


  293. SCHODER H, Zelenetz A, Hamlin P, Gavane S, et al
    Prospective Study of FLT PET for Early Interim Response Assessment in Advanced Stage B-cell Lymphoma.
    J Nucl Med. 2015 Dec 30. pii: jnumed.115.166769.
    PubMed     Text format     Abstract available


  294. GROHEUX D, Biard L, Giacchetti S, Teixeira L, et al
    18FDG-PET/CT for the early evaluation of response to neoadjuvant treatment in triple negative breast cancer: influence of the chemotherapy regimen.
    J Nucl Med. 2015 Dec 23. pii: jnumed.115.163907.
    PubMed     Text format     Abstract available


  295. TAGO T, Furumoto S, Okamura N, Harada R, et al
    Structure-Activity Relationship of 2-Arylquinolines as PET Imaging Tracers for Tau Pathology in Alzheimer's Disease.
    J Nucl Med. 2015 Dec 23. pii: jnumed.115.166652.
    PubMed     Text format     Abstract available


  296. SCHACHT AC, Sorensen M, Munk OL, Frisch K, et al
    Radiosynthesis of novel N-11C-methyl-taurine conjugated bile acids and biodistribution studies in pigs by PET/CT.
    J Nucl Med. 2015 Dec 23. pii: jnumed.115.161711.
    PubMed     Text format     Abstract available


  297. OPREA-LAGER DE, Kramer G, van de Ven P, van den Eertwegh A, et al
    Repeatability of quantitative 18F-fluoromethylcholine PET/CT studies in prostate cancer.
    J Nucl Med. 2015 Dec 23. pii: jnumed.115.167692.
    PubMed     Text format     Abstract available


  298. VIVASH LE, O'Brien TJ
    Imaging microglial activation with TSPO PET: Lighting up neurological diseases?
    J Nucl Med. 2015 Dec 23. pii: jnumed.114.141713.
    PubMed     Text format     Abstract available


  299. AN HJ, Seo S, Kang H, Choi H, et al
    MRI-Based Attenuation Correction for PET/MRI Using Multiphase Level-Set Method.
    J Nucl Med. 2015 Dec 23. pii: jnumed.115.163550.
    PubMed     Text format     Abstract available


  300. GROGG K, Toole T, Ouyang J, Zhu X, et al
    NEMA and clinical evaluation of a novel brain PET-CT scanner.
    J Nucl Med. 2015 Dec 23. pii: jnumed.115.159723.
    PubMed     Text format     Abstract available


  301. KIM SJ, Cho YS, Moon SH, Bae JM, et al
    Primary Tumor FDG Avidity Affects the Performance of FDG PET/CT for Detecting Gastric Cancer Recurrence.
    J Nucl Med. 2015 Dec 17. pii: jnumed.115.163295.
    PubMed     Text format     Abstract available


  302. HOOGENDAM JP, Zweemer RP, Hobbelink MG, van den Bosch MA, et al
    99mTc-nanocolloid SPECT-MRI fusion for the selective assessment of non-enlarged sentinel lymph nodes in patients with early stage cervical cancer.
    J Nucl Med. 2015 Dec 17. pii: jnumed.115.164780.
    PubMed     Text format     Abstract available


  303. DIVINE MR, Katiyar P, Kohlhofer U, Quintanilla-Martinez L, et al
    A Population Based Gaussian Mixture Model Incorporating 18F-FDG-PET and DW-MRI Quantifies Tumor Tissue Classes.
    J Nucl Med. 2015 Dec 10. pii: jnumed.115.163972.
    PubMed     Text format     Abstract available


  304. IQBAL R, Kramer GM, Verwer EE, Huisman MC, et al
    Multiparametric analysis of the relationship between tumor hypoxia and perfusion using 18F-FAZA and 15O-H2O PET.
    J Nucl Med. 2015 Dec 10. pii: jnumed.115.166579.
    PubMed     Text format     Abstract available


  305. SCHOLTENS AM, Verberne HJ, Budde RP, Lam M, et al
    Additional heparin pre-administration improves cardiac glucose metabolism suppression over low carbohydrate diet alone in 18F-FDG-PET imaging.
    J Nucl Med. 2015 Dec 10. pii: jnumed.115.166884.
    PubMed     Text format     Abstract available


  306. MINAMIMOTO R, Hancock S, Schneider B, Chin F, et al
    Pilot Comparison of 68Ga-RM2 PET and 68Ga-PSMA PET in Patients with Biochemically Recurrent Prostate Cancer.
    J Nucl Med. 2015 Dec 10. pii: jnumed.115.168393.
    PubMed     Text format     Abstract available


  307. FUKUSHIMA Y, Kumita SI, Tokita Y, Sato N, et al
    Prognostic value of myocardial perfusion SPECT following intravenous bolus administration of nicorandil in patients with acute ischemic heart failure.
    J Nucl Med. 2015 Dec 3. pii: jnumed.115.162420.
    PubMed     Text format     Abstract available


  308. DE SWART J, Chan HS, Goorden MC, Morgenstern A, et al
    Utilizing high-energy gamma photons for high-resolution 213Bi SPECT in mice.
    J Nucl Med. 2015 Dec 3. pii: jnumed.115.157685.
    PubMed     Text format     Abstract available


  309. ARULAPPU A, Battle M, Eisenblaetter M, McRobbie G, et al
    c-Met PET Imaging Detects Early Stage Loco-Regional Recurrence of Basal-Like Breast Cancer.
    J Nucl Med. 2015 Dec 3. pii: jnumed.115.164384.
    PubMed     Text format     Abstract available


  310. PRIOR JO, Peguret N, Pomoni A, Pappon M, et al
    Reduction of Respiratory Motion during PET/CT by Pulsatile-Flow Ventilation (PFV-PET/CT): A First Clinical Evaluation.
    J Nucl Med. 2015 Dec 3. pii: jnumed.115.163386.
    PubMed     Text format     Abstract available


  311. NOTNI J, Steiger K, Hoffmann F, Reich D, et al
    Complementary, Selective PET-Imaging of Integrin Subtypes alpha5beta1 and alphavbeta3 Using Ga-68-Aquibeprin and Ga-68-Avebetrin.
    J Nucl Med. 2015 Dec 3. pii: jnumed.115.165720.
    PubMed     Text format     Abstract available


  312. MACDONALD L, Hippe D, Bender L, Cotter E, et al
    Positron emission mammography image interpretation for reduced image count levels.
    J Nucl Med. 2015 Dec 3. pii: jnumed.115.165787.
    PubMed     Text format     Abstract available


    November 2015
  313. AARNTZEN E, Hermsen R, Drenth J, Boerman O, et al
    Tc-99m-CXCL8 SPECT to monitor disease activity in inflammatory bowel disease.
    J Nucl Med. 2015 Nov 25. pii: jnumed.115.165795.
    PubMed     Text format     Abstract available


  314. NIU G, Chen X
    RGD PET: From Lesion Detection to Therapy Response Monitoring.
    J Nucl Med. 2015 Nov 25. pii: jnumed.115.168278.
    PubMed     Text format    


  315. KIST JW, de Keizer B, van der Vlies M, Brouwers AH, et al
    124I PET/CT to predict the outcome of blind 131I treatment in patients with biochemical recurrence of differentiated thyroid cancer; results of a multicenter diagnostic cohort study (THYROPET).
    J Nucl Med. 2015 Nov 25. pii: jnumed.115.168138.
    PubMed     Text format     Abstract available


  316. RUF J, von Wedel F, Furth C, Denecke T, et al
    Significance of a single time point hybrid-protocol for somatostatin receptor SPECT including multiphase CT in the diagnostic work-up of gastroenteoropancreatic neuroendocrine Neoplasms (GEP-NEN).
    J Nucl Med. 2015 Nov 25. pii: jnumed.115.161117.
    PubMed     Text format     Abstract available


  317. MICHL M, Lehner S, Paprottka PM, Ilhan H, et al
    PET response criteria (PERCIST) predict progression-free survival and overall survival after radioembolization for liver metastases from pancreatic cancer.
    J Nucl Med. 2015 Nov 25. pii: jnumed.115.165613.
    PubMed     Text format     Abstract available


  318. LOPEZ-RODRIGUEZ V, Galindo-Sarco C, Garcia-Perez FO, Ferro-Flores G, et al
    PET-Based Human Dosimetry of the Dimeric alphavbeta3 Integrin Ligand 68Ga-DOTA-E-[c(RGDfK)]2, a Potential Tracer for Imaging Tumor Angiogenesis.
    J Nucl Med. 2015 Nov 19. pii: jnumed.115.161653.
    PubMed     Text format     Abstract available


  319. PYKA T, Weirich G, Einspieler I, Maurer T, et al
    [68Ga]PSMA-HBED PET for differential diagnosis of suspicious lung lesions in patients with prostate cancer.
    J Nucl Med. 2015 Nov 19. pii: jnumed.115.164442.
    PubMed     Text format     Abstract available


  320. WATANABE S, Kato H, Shimosegawa E, Hatazawa J, et al
    Genetic and Environmental Influences on Regional Brain Uptake of 2-deoxy-2-[18F]fluoro-D-glucose: a PET Study in Monozygotic and Dizygotic Twins.
    J Nucl Med. 2015 Nov 19. pii: jnumed.115.164004.
    PubMed     Text format     Abstract available


  321. TAHMASIAN M, Shao J, Meng C, Grimmer T, et al
    Based on the network degeneration hypothesis: separating individual patients with different neurodegenerative syndromes in a preliminary hybrid PET/MR study.
    J Nucl Med. 2015 Nov 19. pii: jnumed.115.165464.
    PubMed     Text format     Abstract available


  322. GRIMMER T, Wutz C, Alexopoulos P, Drzezga A, et al
    Visual versus fully-automated analyses of FDG- and Amyloid-PET for prediction of dementia due to Alzheimer's disease in mild cognitive impairment.
    J Nucl Med. 2015 Nov 19. pii: jnumed.115.163717.
    PubMed     Text format     Abstract available


  323. SHUKURI M, Mawatari A, Ohno M, Suzuki M, et al
    Detection of cyclooxygenase-1 in activated microglia during amyloid plaque progression: PET studies in Alzheimer's disease model mice.
    J Nucl Med. 2015 Nov 19. pii: jnumed.115.166116.
    PubMed     Text format     Abstract available


  324. LI F, Jorgensen JT, Forman J, Hansen AE, et al
    64Cu-ATSM reflects pO2 levels in human head and neck cancer xenografts but not in colorectal cancer xenografts.
    J Nucl Med. 2015 Nov 19. pii: jnumed.115.155663.
    PubMed     Text format     Abstract available


  325. JALLOW N, Christian PE, Sunderland J, Graham MM, et al
    Diagnostic Reference Levels of CT Radiation Dose in Oncology Whole-Body PET/CT.
    J Nucl Med. 2015 Nov 12. pii: jnumed.115.160465.
    PubMed     Text format     Abstract available


  326. KIM EE
    Therapeutic Nuclear Medicine.
    J Nucl Med. 2015 Nov 12. pii: jnumed.115.169300.
    PubMed     Text format    


  327. JANSSEN I, Chen CC, Taieb D, Patronas NJ, et al
    68Ga-DOTATATE PET/CT in the localization of head and neck paragangliomas compared to other functional imaging modalities and CT/MRI.
    J Nucl Med. 2015 Nov 12. pii: jnumed.115.161018.
    PubMed     Text format     Abstract available


  328. SPIELMANN V, Li WB, Zankl M, Oeh U, et al
    Uncertainty Quantification in Internal Dose Calculations for Seven Selected Radiopharmaceuticals.
    J Nucl Med. 2015 Nov 12. pii: jnumed.115.160713.
    PubMed     Text format     Abstract available


  329. KANAZAWA M, Ohba H, Harada N, Kakiuchi T, et al
    Evaluation of 6-11C-Methyl-m-tyrosine as a PET Probe for Presynaptic Dopaminergic Activity: A Comparison PET Study with beta-11-L-DOPA and 18F-FDOPA in Parkinson's Disease Monkeys.
    J Nucl Med. 2015 Nov 12. pii: jnumed.115.161802.
    PubMed     Text format     Abstract available


  330. CHENG SH, Yu D, Tsai HM, Morshed RA, et al
    Dynamic In Vivo SPECT Imaging of Neural Stem Cells Functionalized with Radiolabeled Nanoparticles for Tracking of Glioblastoma.
    J Nucl Med. 2015 Nov 12. pii: jnumed.115.163006.
    PubMed     Text format     Abstract available


  331. LAFFON E, Burger IA, Lamare F, de Clermont-Gallerande H, et al
    SUVpeak performance in Lung Cancer: Comparison to Average SUV from 40 Hottest Voxels.
    J Nucl Med. 2015 Nov 12. pii: jnumed.115.161968.
    PubMed     Text format     Abstract available


  332. CIVELEK AC
    New Insights: PET imaging to document synergistic therapy effect of the 'old'-ancient recipe, and the 'new'-modern drug in stroke.
    J Nucl Med. 2015 Nov 5. pii: jnumed.115.166702.
    PubMed     Text format    


  333. LUO H, England CG, Graves SA, Sun H, et al
    PET Imaging of VEGFR-2 Expression in Lung Cancer with 64Cu-labeled Ramucirumab.
    J Nucl Med. 2015 Nov 5. pii: jnumed.115.166462.
    PubMed     Text format     Abstract available


  334. RULLMANN M, Dukart J, Hoffmann KT, Luthardt J, et al
    Partial volume effect correction improves quantitative florbetaben beta-amyloid PET scan analysis.
    J Nucl Med. 2015 Nov 5. pii: jnumed.115.161893.
    PubMed     Text format     Abstract available


  335. ZHOU H, Shen G, Zhang W, Cai H, et al
    18F-FDG PET/CT for the diagnosis of residual or recurrent nasopharyngeal carcinoma after radiotherapy: a meta-analysis.
    J Nucl Med. 2015 Nov 5. pii: jnumed.115.165407.
    PubMed     Text format     Abstract available


  336. HARADA R, Okamura N, Furumoto S, Furukawa K, et al
    18F-THK5351: A Novel PET Radiotracer for Imaging Neurofibrillary Pathology in Alzheimer's Disease.
    J Nucl Med. 2015 Nov 5. pii: jnumed.115.164848.
    PubMed     Text format     Abstract available


  337. PARKER JA
    From the ABNM: Practice of Nuclear Medicine.
    J Nucl Med. 2015;56:18N.
    PubMed     Text format    


  338. MAHMOOD U
    2015 SNMMI Highlights Lecture: Oncology, Part I.
    J Nucl Med. 2015;56:9N-16N.
    PubMed     Text format    


  339. JADVAR H
    SNMMI Leadership Update: Developing Evidence-Based Appropriate Use Criteria under the Protecting Access to Medicare Act of 2014.
    J Nucl Med. 2015;56:20N.
    PubMed     Text format    


  340. JERAJ R, Bradshaw T, Simoncic U
    Molecular Imaging to Plan Radiotherapy and Evaluate Its Efficacy.
    J Nucl Med. 2015;56:1752-65.
    PubMed     Text format     Abstract available


  341. WAHL RL, Horner TJ, Lin TS, Kaminski MS, et al
    Observational Retrospective Study of Altered Biodistribution of Tositumomab and 131I-Tositumomab.
    J Nucl Med. 2015;56:1800-3.
    PubMed     Text format     Abstract available


  342. ILHAN H, Goritschan A, Paprottka P, Jakobs TF, et al
    Predictive Value of 99mTc-MAA SPECT for 90Y-Labeled Resin Microsphere Distribution in Radioembolization of Primary and Secondary Hepatic Tumors.
    J Nucl Med. 2015;56:1654-60.
    PubMed     Text format     Abstract available


  343. FROKLAGE FE, Boellaard R, Bakker E, Hendrikse NH, et al
    Quantification of 11C-Laniquidar Kinetics in the Brain.
    J Nucl Med. 2015;56:1730-5.
    PubMed     Text format     Abstract available


  344. DUBROFF JG, Doot RK, Falcone M, Schnoll RA, et al
    Decreased Nicotinic Receptor Availability in Smokers with Slow Rates of Nicotine Metabolism.
    J Nucl Med. 2015;56:1724-9.
    PubMed     Text format     Abstract available


    October 2015
  345. ZANOTTI-FREGONARA P, Xu R, Zoghbi SS, Liow JS, et al
    The positron emission tomographic radioligand 18F-FIMX images and quantifies metabotropic glutamate receptor 1 in proportion to the regional density of its gene transcript in human brain.
    J Nucl Med. 2015 Oct 29. pii: jnumed.115.162461.
    PubMed     Text format     Abstract available


  346. SAWICKI LM, Grueneisen J, Buchbender C, Schaarschmidt BM, et al
    Evaluation of the outcome of lung nodules missed on 18F-FDG PET/MRI compared to 18F-FDG PET/CT in patients with known malignancies.
    J Nucl Med. 2015 Oct 29. pii: jnumed.115.162966.
    PubMed     Text format     Abstract available


  347. RYLOVA SN, Del Pozzo L, Klingeberg C, Tonnesmann R, et al
    Immuno-PET imaging of CD30 positive lymphoma using 89Zr-DFO-AC-10.
    J Nucl Med. 2015 Oct 29. pii: jnumed.115.162735.
    PubMed     Text format     Abstract available


  348. ZHANG H, Liu N, Gao S, Hu X, et al
    Can a Novel 18F-ALF-NOTA-PRGD2 PET/CT Predict the Treatment Sensitivity of Concurrent Chemoradiotherapy in Patients with Newly Diagnosed Glioblastoma?
    J Nucl Med. 2015 Oct 29. pii: jnumed.115.165514.
    PubMed     Text format     Abstract available


  349. SEKINE T, Buck A, Delso G, Ter Voert E, et al
    Evaluation of atlas-based attenuation correction for integrated PET/MR in human brain - application of a head atlas and comparison to true CT-based attenuation correction.
    J Nucl Med. 2015 Oct 22. pii: jnumed.115.159228.
    PubMed     Text format     Abstract available


  350. KURLAND BF, Muzi M, Peterson LM, Doot RK, et al
    Multicenter clinical trials using 18F-FDG PET to measure early oncology therapy response: Effects of injection-to-acquisition time variability on required sample size.
    J Nucl Med. 2015 Oct 22. pii: jnumed.115.162289.
    PubMed     Text format     Abstract available


  351. BEIJST C, Kist JW, Elschot M, Viergever M, et al
    Quantitative comparison of I-124 PET/CT and I-131 SPECT/CT detectability.
    J Nucl Med. 2015 Oct 22. pii: jnumed.115.162750.
    PubMed     Text format     Abstract available


  352. TORRADO-CARVAJAL A, Herraiz JL, Alcain E, Montemayor AS, et al
    Fast Patch-Based Pseudo-CT Synthesis from T1-Weighted MR Images for PET/MR Attenuation Correction in Brain Studies.
    J Nucl Med. 2015 Oct 22. pii: jnumed.115.156299.
    PubMed     Text format     Abstract available


  353. ROWE SP, Macura KJ, Ciarallo A, Mena E, et al
    Comparison of PSMA-based 18F-DCFBC PET/CT to Conventional Imaging Modalities for Detection of Hormone-Sensitive and Castration-Resistant Metastatic Prostate Cancer.
    J Nucl Med. 2015 Oct 22. pii: jnumed.115.163782.
    PubMed     Text format     Abstract available


  354. AKLAN B, Oehmigen M, Beiderwellen K, Ruhlmann M, et al
    Impact of Point-Spread Function (PSF) Modeling on PET Image Quality in Integrated PET/MR Hybrid Imaging.
    J Nucl Med. 2015 Oct 15. pii: jnumed.115.154757.
    PubMed     Text format     Abstract available


  355. HUELLNER MW, Barbosa FG, Husmann L, Pietsch CM, et al
    TNM staging of NSCLC: Comparison of PET/MR and PET/CT.
    J Nucl Med. 2015 Oct 15. pii: jnumed.115.162040.
    PubMed     Text format     Abstract available


  356. SKOURA E, Michopoulou S, Mohmaduvesh M, Panagiotidis E, et al
    The impact of 68Ga-DOTATATE PET/CT imaging on management of patients with neuroendocrine tumours: Experience from a national referral centre in the United Kingdom.
    J Nucl Med. 2015 Oct 15. pii: jnumed.115.166017.
    PubMed     Text format     Abstract available


  357. CHAE SY, Choi CM, Shim TS, Park Y, et al
    Exploratory Clinical Investigation of (4S)-4-(3-18F-Fluoropropyl)-L-Glutamate Positron Emission Tomography of Inflammatory and Infectious Lesions.
    J Nucl Med. 2015 Oct 15. pii: jnumed.115.164020.
    PubMed     Text format     Abstract available


  358. LJUNGBERG M, Celler A, Konijnenberg MW, Eckerman KF, et al
    MIRD Pamphlet No. 26: Joint EANM/MIRD Guidelines for Quantitative 177Lu SPECT applied for Dosimetry of Radiopharmaceutical Therapy.
    J Nucl Med. 2015 Oct 15. pii: jnumed.115.159012.
    PubMed     Text format     Abstract available


  359. RUBEAUX M, Joshi N, Dweck MR, Fletcher A, et al
    Motion correction of 18F-sodium fluoride PET for imaging coronary atherosclerotic plaques.
    J Nucl Med. 2015 Oct 15. pii: jnumed.115.162990.
    PubMed     Text format     Abstract available


  360. KLENK C, Gawande R, Tran VT, Trinh J, et al
    Progressing towards a cohesive pediatric 18F-FDG PET/MR protocol: Is the administration of Gadolinium-Chelates necessary?
    J Nucl Med. 2015 Oct 15. pii: jnumed.115.161646.
    PubMed     Text format     Abstract available


  361. ZHANG J, Li D, Lang L, Zhu Z, et al
    68Ga-NOTA-Aca-BBN(7-14) PET/CT in Healthy Volunteers and Glioma Patients.
    J Nucl Med. 2015 Oct 8. pii: jnumed.115.165316.
    PubMed     Text format     Abstract available


  362. KEYAERTS M, Xavier C, Heemskerk J, Devoogdt N, et al
    Phase I study of 68Ga-HER2-Nanobody for PET/CT assessment of HER2-expression in breast carcinoma.
    J Nucl Med. 2015 Oct 8. pii: jnumed.115.162024.
    PubMed     Text format     Abstract available


  363. KRIZSAN AK, Lajtos I, Dahlbom M, Daver F, et al
    Promising future: Comparable Imaging Capability of MRI compatible SiPM and Conventional Photo-sensor Based Preclinical PET Systems.
    J Nucl Med. 2015 Oct 8. pii: jnumed.115.157677.
    PubMed     Text format     Abstract available


  364. BAGUNA TORRES J, Andreozzi E, Dunn J, Siddique M, et al
    PET Imaging of Copper Trafficking in a Mouse Model of Alzheimer's Disease.
    J Nucl Med. 2015 Oct 8. pii: jnumed.115.162370.
    PubMed     Text format     Abstract available


  365. ZHENG K, Liang N, Zhang J, Lang L, et al
    68Ga-NOTA-PRGD2 PET/CT for Integrin Imaging in Patients with Lung Cancer.
    J Nucl Med. 2015 Oct 1. pii: jnumed.115.160648.
    PubMed     Text format     Abstract available


  366. KIM EE
    Molecular Anatomic Imaging: PET/CT, PET/MR and SPECT/CT, third edition.
    J Nucl Med. 2015 Oct 1. pii: jnumed.115.167130.
    PubMed     Text format    


  367. GUNGOR H, Saleem A, Babar S, Dina R, et al
    Dose-finding quantitative FDG PET imaging study with the oral pan-AKT inhibitor GSK2141795 in patients with gynecological malignancies.
    J Nucl Med. 2015 Oct 1. pii: jnumed.115.156505.
    PubMed     Text format     Abstract available


  368. CZERNIN J
    Reply: Multiple Perspectives on Nuclear Medicine Training.
    J Nucl Med. 2015 Oct 1. pii: jnumed.115.166181.
    PubMed     Text format    


  369. OSBORNE JR, Beylergil V, Sammit C, Graham MM, et al
    Letter: Multiple Perspectives on Nuclear Medicine Training.
    J Nucl Med. 2015 Oct 1. pii: jnumed.115.165621.
    PubMed     Text format    


  370. WEBER WA, Gatsonis C, Siegel B
    Reply: Repeatability of Tumor SUV Quantification: The Role of Variable Blood SUV.
    J Nucl Med. 2015;56:1636.
    PubMed     Text format    


  371. VAN DEN HOFF J, Hofheinz F
    Repeatability of Tumor SUV Quantification: The Role of Variable Blood SUV.
    J Nucl Med. 2015;56:1635-6.
    PubMed     Text format    


  372. BOHNEN NI
    2015 SNMMI Highlights Lecture: Neurosciences.
    J Nucl Med. 2015;56:13N-20N.
    PubMed     Text format    


  373. COLLAMATI F, Bellini F, Bocci V, De Lucia E, et al
    Time Evolution of DOTATOC Uptake in Neuroendocrine Tumors in View of a Possible Application of Radioguided Surgery with beta- Decay.
    J Nucl Med. 2015;56:1501-6.
    PubMed     Text format     Abstract available


  374. OLIVEIRA BL, Blasi F, Rietz TA, Rotile NJ, et al
    Multimodal Molecular Imaging Reveals High Target Uptake and Specificity of 111In- and 68Ga-Labeled Fibrin-Binding Probes for Thrombus Detection in Rats.
    J Nucl Med. 2015;56:1587-92.
    PubMed     Text format     Abstract available


  375. SELIVANOVA SV, Lavallee E, Senta H, Caouette L, et al
    Radioisotopic Purity of Sodium Pertechnetate 99mTc Produced with a Medium-Energy Cyclotron: Implications for Internal Radiation Dose, Image Quality, and Release Specifications.
    J Nucl Med. 2015;56:1600-8.
    PubMed     Text format     Abstract available


  376. PERSSON M, Nedergaard M, Brandt-Larsen M, Skovgaard D, et al
    uPAR is a Promising New Imaging Biomarker in Glioblastoma.
    J Nucl Med. 2015 Oct 1. pii: jnumed.115.161703.
    PubMed     Text format     Abstract available


    September 2015
  377. DE LAAT B, Leurquin-Sterk G, Celen S, Bormans G, et al
    Preclinical evaluation and quantification of 18F-FPEB as a radioligand for PET imaging of the metabotropic glutamate receptor 5.
    J Nucl Med. 2015 Sep 24. pii: jnumed.115.162636.
    PubMed     Text format     Abstract available


  378. SLOMKA PJ PHD, Rubeaux M PhD, Le Meunier L PhD, Dey D PhD, et al
    Dual-Gated Motion-Frozen Cardiac PET with Flurpiridaz F18.
    J Nucl Med. 2015 Sep 24. pii: jnumed.115.164285.
    PubMed     Text format     Abstract available


  379. HARTENBACH M, Weber S, Albert NL, Hartenbach S, et al
    Evaluating treatment response of radioembolization in intermediate stage hepatocellular carcinoma patients using 18Fluoroethylcholine-PET/CT.
    J Nucl Med. 2015 Sep 24. pii: jnumed.115.158758.
    PubMed     Text format     Abstract available


  380. AMBROSINI V, Campana D, Polverari G, Peterle C, et al
    Prognostic value of 68Ga-DOTA-NOC PET/CT SUVmax in patients with neuroendocrine tumours of the pancreas.
    J Nucl Med. 2015 Sep 24. pii: jnumed.115.162719.
    PubMed     Text format     Abstract available


  381. MINAMIMOTO R, Loening A, Jamali M, Barkhodari A, et al
    Prospective Comparison of 99mTc MDP Scintigraphy, Combined 18F-NaF and 18F-FDG PET/CT and Whole-Body MRI in Patients with Breast and Prostate Cancers.
    J Nucl Med. 2015 Sep 24. pii: jnumed.115.162610.
    PubMed     Text format     Abstract available


  382. INCERTI E, Fodor A, Mapelli P, Fiorino C, et al
    Radiation treatment of lymph node recurrence from prostate cancer: is 11C-choline PET/CT predictive of survival outcomes?
    J Nucl Med. 2015 Sep 24. pii: jnumed.115.163741.
    PubMed     Text format     Abstract available


  383. ALESSIO AM, Farrell MB, Fahey FH
    Role of Reference Levels in Nuclear Medicine: A Report of the SNMMI Dose Optimization Task Force.
    J Nucl Med. 2015 Sep 24. pii: jnumed.115.160861.
    PubMed     Text format    


  384. SHARMA R, Kallur K, Ryu J, Parameswaran R, et al
    Multi-Centre Reproducibility of 18F-Fluciclatide PET Imaging in Subjects with Solid Tumors.
    J Nucl Med. 2015 Sep 17. pii: jnumed.115.158253.
    PubMed     Text format     Abstract available


  385. PARKER CA, Rabiner EI, Gunn R, Searle G, et al
    Human kinetic modelling of the 5-HT6 PET radioligand, 11C-GSK215083, and its utility for determining occupancy at both 5HT6 and 5HT2A receptors by SB742457 as a potential therapeutic mechanism of action in Alzheimer's disease.
    J Nucl Med. 2015 Sep 17. pii: jnumed.115.162743.
    PubMed     Text format     Abstract available


  386. VAN DER VOS CS, Grootjans W, Osborne DR, Meeuwis AP, et al
    Improving the spatial alignment in PET/CT using amplitude-based respiratory gated PET and respiratory triggered CT.
    J Nucl Med. 2015 Sep 17. pii: jnumed.115.163055.
    PubMed     Text format     Abstract available


  387. NIELSEN CH, Erlandsson M, Jeppesen TE, Jensen MM, et al
    Quantitative PET Imaging of Tissue Factor Expression Using 18F-labled Active Site Inhibited Factor VII.
    J Nucl Med. 2015 Sep 17. pii: jnumed.115.154849.
    PubMed     Text format     Abstract available


  388. UMEDA Y, Demura Y, Morikawa M, Anzai M, et al
    Prognostic value of dual-time-point [18F]-2-fluoro-2-deoxyglucose PET for idiopathic pulmonary fibrosis.
    J Nucl Med. 2015 Sep 10. pii: jnumed.115.163360.
    PubMed     Text format     Abstract available


  389. HOSOKAWA C, Ishii K, Kimura Y, Hyodo T, et al
    Performance of 11C-PiB PET binding potential images in the equivocal static images in the detection of amyloid deposits.
    J Nucl Med. 2015 Sep 10. pii: jnumed.115.156414.
    PubMed     Text format     Abstract available


  390. BLANCHET E, Taieb D, Millo C, Martucci V, et al
    18F-FLT PET/CT in the evaluation of pheochromocytomas and paragangliomas: A pilot study.
    J Nucl Med. 2015 Sep 10. pii: jnumed.115.159061.
    PubMed     Text format     Abstract available


  391. KANZAKI Y, Yamauchi Y, Morita H, Hayashi M, et al
    Presence of Post-systolic Shortening Increases the Likelihood of Coronary Artery Disease: A Rest ECG-gated Myocardial Perfusion SPECT Study.
    J Nucl Med. 2015 Sep 10. pii: jnumed.115.153791.
    PubMed     Text format     Abstract available


  392. ZHANG H, Song F, Xu C, Liu H, et al
    Spatiotemporal PET imaging of dynamic metabolic changes after combined therapeutic approach of induced pluripotent stem cells (iPSCs), neuronal stem cells (NSCs) and Chinese patent medicine in a rat model of cerebral ischemic-reperfusion injury.
    J Nucl Med. 2015 Sep 10. pii: jnumed.115.163170.
    PubMed     Text format     Abstract available


  393. KOSTAKOGLU L, Duan F, Idowu MO, Jolles PR, et al
    A Phase II Study of [(18)F]-3'Deoxy-3'-Fluorothymidine Positron Emission Tomography (FLT-PET) in The Asessment of Early Response of Breast Cancer to Neoadjuvant Chemotherapy: Results From ACRIN 6688.
    J Nucl Med. 2015 Sep 10. pii: jnumed.115.160663.
    PubMed     Text format     Abstract available


  394. TRAXL A, Wanek T, Mairinger S, Stanek J, et al
    Breast Cancer Resistance Protein and P-glycoprotein Influence In Vivo Disposition of 11C-Erlotinib.
    J Nucl Med. 2015 Sep 10. pii: jnumed.115.161273.
    PubMed     Text format     Abstract available


  395. GUTTE H, Hansen AE, Larsen M, Rahbek S, et al
    Simultaneous hyperpolarized 13C-pyruvate MRI and 18F-FDG-PET (hyperPET) in 10 canine cancer patients.
    J Nucl Med. 2015 Sep 3. pii: jnumed.115.156364.
    PubMed     Text format     Abstract available


  396. JOSHI AD, Pontecorvo MJ, Skovronsky DM, Mintun MA, et al
    A semi-automated method for quantification of florbetapir F 18 PET images.
    J Nucl Med. 2015 Sep 3. pii: jnumed.114.153494.
    PubMed     Text format     Abstract available


  397. BEN BOUALLEGUE F, Roubille F, Lattuca B, Cung TT, et al
    SPECT Myocardial Perfusion Reserve in Patients with Multivessel Coronary Disease: Correlation with Angiographic Findings and Invasive Fractional Flow Reserve Measurements.
    J Nucl Med. 2015 Sep 3. pii: jnumed.114.143164.
    PubMed     Text format     Abstract available


  398. LE ROUX PY, Siva S, Steinfort DP, Callahan J, et al
    Correlation of 68Gallium ventilation-perfusion PET/CT with pulmonary function test indices for assessing lung function.
    J Nucl Med. 2015 Sep 3. pii: jnumed.115.162586.
    PubMed     Text format     Abstract available


  399. GORDON L, Metter D, Elman S
    Women in Nuclear Medicine.
    J Nucl Med. 2015;56:20N.
    PubMed     Text format    


  400. SEGALL G
    Nuclear Medicine, Social Media, and Two Degrees of Separation.
    J Nucl Med. 2015;56:19N.
    PubMed     Text format    


  401. FREY KA
    Reply: Alzheimer Disease: Approaches to Early Diagnosis and High-Accuracy Imaging.
    J Nucl Med. 2015;56:1467.
    PubMed     Text format    


  402. MACHULLA HJ
    Alzheimer Disease: Approaches to Early Diagnosis and High-Accuracy Imaging.
    J Nucl Med. 2015;56:1466-7.
    PubMed     Text format    


  403. DILSIZIAN V
    2015 SNMMI Highlights Lecture: Cardiovascular Nuclear and Molecular Imaging.
    J Nucl Med. 2015;56:13N-9N.
    PubMed     Text format    


  404. KING MT, Carpenter CM, Sun C, Ma X, et al
    beta-Radioluminescence Imaging: A Comparative Evaluation with Cerenkov Luminescence Imaging.
    J Nucl Med. 2015;56:1458-64.
    PubMed     Text format     Abstract available


  405. ZIMMERMAN BE, Bergeron DE, Cessna JT
    Impact of Recent Change in the National Institute of Standards and Technology Standard for 18F on the Relative Response of 68Ge-Based Mock Syringe Dose Calibrator Standards.
    J Nucl Med. 2015;56:1453-7.
    PubMed     Text format     Abstract available


  406. VAN DUIJNHOVEN SM, Rossin R, van den Bosch SM, Wheatcroft MP, et al
    Diabody Pretargeting with Click Chemistry In Vivo.
    J Nucl Med. 2015;56:1422-8.
    PubMed     Text format     Abstract available


  407. MAURER AH
    Gastrointestinal Motility, Part 2: Small-Bowel and Colon Transit.
    J Nucl Med. 2015;56:1395-400.
    PubMed     Text format     Abstract available


  408. KEIDING S
    How Should Lumped Constant Be Estimated for Hepatic 18F-FDG Glucose in Humans?
    J Nucl Med. 2015;56:1302-3.
    PubMed     Text format    


  409. MACHULLA HJ
    Imaging of Apoptosis: The Need to Distinguish Tracer Uptake Rate from Regional Contribution of Blood Flow.
    J Nucl Med. 2015;56:1300-1.
    PubMed     Text format    


    August 2015
  410. JACOBSON O, Weiss I, Wang L, Wang Z, et al
    18F-labeled Single-Stranded DNA Aptamer for PET Imaging of Protein Tyrosine Kinase-7 Expression.
    J Nucl Med. 2015 Aug 27. pii: jnumed.115.160960.
    PubMed     Text format     Abstract available


  411. RENDON DA, Kotedia K, Afshar SF, Punia JN, et al
    Mapping radiation injury and recovery in bone marrow using 18F-FLT PET/CT and USPIO-MR imaging in a rat model.
    J Nucl Med. 2015 Aug 27. pii: jnumed.115.158121.
    PubMed     Text format     Abstract available


  412. GEWIRTZ H
    SPECT MPI: Post stress, end systolic images and the ongoing effort to improve diagnostic accuracy.
    J Nucl Med. 2015 Aug 27. pii: jnumed.115.164111.
    PubMed     Text format    


  413. BURT T, Rouse D, Lee K, Wu H, et al
    Intra-Arterial Microdosing (IAM): A Novel Drug Development Approach, Proof-of-Concept PET Study in Rats.
    J Nucl Med. 2015 Aug 27. pii: jnumed.115.160986.
    PubMed     Text format     Abstract available


  414. ANAND A, Morris MJ, Kaboteh R, Bath L, et al
    Analytical Validation of the Automated Bone Scan Index as an Imaging Biomarker to Standardize the Quantitative Changes in Bone Scans of Patients with Metastatic Prostate Cancer.
    J Nucl Med. 2015 Aug 27. pii: jnumed.115.160085.
    PubMed     Text format     Abstract available


  415. CHOI H, Lee DS
    PET and SPECT of Neurobiological Systems.
    J Nucl Med. 2015 Aug 20. pii: jnumed.115.164616.
    PubMed     Text format    


  416. FINK J, Muzi M, Peck M, Krohn KA, et al
    Multi-modality Brain Tumor Imaging - MRI, PET, and PET/MRI.
    J Nucl Med. 2015 Aug 20. pii: jnumed.113.131516.
    PubMed     Text format     Abstract available


  417. CHOI H, Lee DS
    PET and SPECT in Psychiatry.
    J Nucl Med. 2015 Aug 20. pii: jnumed.115.164608.
    PubMed     Text format    


  418. IAGARU AH
    18F NaF PET in the Assessment of Malignant Bone Disease.
    J Nucl Med. 2015 Aug 20. pii: jnumed.115.162784.
    PubMed     Text format    


  419. AFSHAR-OROMIEH A, Hetzheim H, Kratochwil C, Benesova M, et al
    The novel theranostic PSMA-ligand PSMA-617 in the diagnosis of prostate cancer by PET/CT: biodistribution in humans, radiation dosimetry and first evaluation of tumor lesions.
    J Nucl Med. 2015 Aug 20. pii: jnumed.115.161299.
    PubMed     Text format     Abstract available


  420. BUVAT I, Orhlac F, Soussan M
    Tumor texture analysis in PET: where do we stand?
    J Nucl Med. 2015 Aug 20. pii: jnumed.115.163469.
    PubMed     Text format    


  421. PARSONS M, Goldman D, Dashevsky B, Riedl CC, et al
    Value of 18F-FDG PET/CT for Systemic Staging of Newly Diagnosed Invasive Lobular Breast Cancer (ILC) as Compared with Invasive Ductal Breast Cancer (IDC).
    J Nucl Med. 2015 Aug 20. pii: jnumed.115.161455.
    PubMed     Text format     Abstract available


  422. STENDAHL J, Sinusas AJ
    Nanoparticles for cardiovascular imaging and therapeutic delivery, Part 2: Radiolabeled probes.
    J Nucl Med. 2015 Aug 20. pii: jnumed.115.164145.
    PubMed     Text format     Abstract available


  423. FRANZ D, Karampinos DC, Rummeny EJ, Souvatzoglou M, et al
    Discrimination between brown and white adipose tissue using a two-point Dixon water-fat separation method in simultaneous PET/MRI.
    J Nucl Med. 2015 Aug 13. pii: jnumed.115.160770.
    PubMed     Text format     Abstract available


  424. KITKUNGVAN D MD, Vejpongsa P Md, Korrane K Md, Sdringola S Md, et al
    Clinical Utility of Enhanced Relative Activity Recovery on Systolic Myocardial Perfusion SPECT - Lessons from PET.
    J Nucl Med. 2015 Aug 13. pii: jnumed.115.153759.
    PubMed     Text format     Abstract available


  425. LEE DS
    Introduction to book series review: 'PET and SPECT in Neurology, PET and SPECT in Psychiatry, and PET and SPECT of Neurobiological Systems'.
    J Nucl Med. 2015 Aug 6. pii: jnumed.115.164582.
    PubMed     Text format    


  426. KIM YK, Lee DS
    PET and SPECT in Neurology.
    J Nucl Med. 2015 Aug 6. pii: jnumed.115.164590.
    PubMed     Text format    


  427. BAUMAN A, Valverde IE, Fischer CA, Vomstein S, et al
    Development of Gallium-68 and Zirconium-89 Labelled Exendin-4 as Potential Radiotracers for the Imaging of Insulinomas by PET.
    J Nucl Med. 2015 Aug 6. pii: jnumed.115.159186.
    PubMed     Text format     Abstract available


  428. MAIER FC, Keller MD, Bukala D, Bender B, et al
    Quantification of beta-amyloidosis and rCBF with dedicated PET, 7 T-MR imaging and high-resolution microscopic MR imaging at 16.4 T in APP23 mice.
    J Nucl Med. 2015 Aug 6. pii: jnumed.115.159350.
    PubMed     Text format     Abstract available


  429. ZHANG J, Lang L, Li F, Zhu Z, et al
    Clinical Translation of a Novel Albumin-Binding PET Radiotracer 68Ga-NEB.
    J Nucl Med. 2015 Aug 6. pii: jnumed.115.159640.
    PubMed     Text format     Abstract available


  430. TASWELL C, Villemagne VL, Yates P, Shimada H, et al
    FDG-PET improves diagnosis in patients presenting with focal onset dementias.
    J Nucl Med. 2015 Aug 6. pii: jnumed.115.161067.
    PubMed     Text format     Abstract available


  431. LEE JW, Jo K, Cho A, Noh SH, et al
    Relationship between 18F-FDG uptake on PET and recurrence patterns after curative surgical resection in patients with advanced gastric cancer.
    J Nucl Med. 2015 Aug 6. pii: jnumed.115.160580.
    PubMed     Text format     Abstract available



  432. SNMMI 2015 Image of the Year.
    J Nucl Med. 2015;56:9N.
    PubMed     Text format    


  433. ZUBAL G
    From the Exhibitors' Hall: SNMMI Annual Meeting 2015.
    J Nucl Med. 2015;56:16N-19N.
    PubMed     Text format    


  434. HU K, Wang H, Tang G, Huang T, et al
    In Vivo Cancer Dual-Targeting and Dual-Modality Imaging with Functionalized Quantum Dots.
    J Nucl Med. 2015;56:1278-84.
    PubMed     Text format     Abstract available


  435. MUZI M, Peterson LM, O'Sullivan JN, Fink JR, et al
    18F-Fluoromisonidazole Quantification of Hypoxia in Human Cancer Patients Using Image-Derived Blood Surrogate Tissue Reference Regions.
    J Nucl Med. 2015;56:1223-8.
    PubMed     Text format     Abstract available


  436. BUTOF R, Hofheinz F, Zophel K, Stadelmann T, et al
    Prognostic Value of Pretherapeutic Tumor-to-Blood Standardized Uptake Ratio in Patients with Esophageal Carcinoma.
    J Nucl Med. 2015;56:1150-6.
    PubMed     Text format     Abstract available


  437. WEINEISEN M, Schottelius M, Simecek J, Baum RP, et al
    68Ga- and 177Lu-Labeled PSMA I&T: Optimization of a PSMA-Targeted Theranostic Concept and First Proof-of-Concept Human Studies.
    J Nucl Med. 2015;56:1169-76.
    PubMed     Text format     Abstract available


  438. MAURER AH
    Gastrointestinal Motility, Part 1: Esophageal Transit and Gastric Emptying.
    J Nucl Med. 2015;56:1229-38.
    PubMed     Text format     Abstract available


  439. NERI D
    Imaging T Cells In Vivo.
    J Nucl Med. 2015;56:1135-6.
    PubMed     Text format    


  440. TAVARE R, McCracken MN, Zettlitz KA, Salazar FB, et al
    Immuno-PET of Murine T Cell Reconstitution Postadoptive Stem Cell Transplantation Using Anti-CD4 and Anti-CD8 Cys-Diabodies.
    J Nucl Med. 2015;56:1258-64.
    PubMed     Text format     Abstract available


    July 2015
  441. JIMENEZ-HEFFERNAN A, Ellman A, Sado HN, Huic D, et al
    Results of a prospective International Atomic Energy Ahency (IAEA) sentinel node trial on the value of SPECT/CT over planar imaging in various malignancies.
    J Nucl Med. 2015 Jul 30. pii: jnumed.114.153643.
    PubMed     Text format     Abstract available


  442. BRUNKEN RC
    Promising New Fluorine-18 Labeled Tracers for PET Myocardial Perfusion Imaging.
    J Nucl Med. 2015 Jul 30. pii: jnumed.115.161661.
    PubMed     Text format    


  443. YAN J, Lim JC, Loi HY, Khor LK, et al
    Impact of image reconstruction settings on Texture Features in 18F-FDG PET.
    J Nucl Med. 2015 Jul 30. pii: jnumed.115.156927.
    PubMed     Text format     Abstract available


  444. HALLE B, Thisgaard H, Hvidsten S, Dam JH, et al
    Estimation of Tumor Volumes by [11C]MeAIB and [18F]FDG PET in an Orthotopic Glioblastoma Rat Model.
    J Nucl Med. 2015 Jul 30. pii: jnumed.115.162511.
    PubMed     Text format     Abstract available


  445. PAEZ D, Orellana P, Gutierrez C, Ramirez R, et al
    Current Status of Nuclear Medicine Practice in Latin America and the Caribbean.
    J Nucl Med. 2015 Jul 30. pii: jnumed.114.148932.
    PubMed     Text format     Abstract available


  446. GHEYSENS O, Postnov A, Deroose CM, Vandermeulen C, et al
    Quantification, Variability and Reproducibility of Basal Skeletal Muscle Glucose Uptake in Lean Healthy Humans using 18F-FDG-PET/CT.
    J Nucl Med. 2015 Jul 30. pii: jnumed.115.159715.
    PubMed     Text format     Abstract available


  447. HELLWIG S, Frings L, Amtage F, Buchert R, et al
    18F-FDG PET is an early predictor of overall survival in suspected atypical parkinsonism.
    J Nucl Med. 2015 Jul 30. pii: jnumed.115.159822.
    PubMed     Text format     Abstract available


  448. WAWRZYNIAK AJ, Dilsizian V, Krantz DS, Harris KM, et al
    High Concordance Between Mental Stress-Induced and Adenosine-Induced Myocardial Ischemia Assessed Using SPECT in Heart Failure Patients: Hemodynamic and Biomarker Correlates.
    J Nucl Med. 2015 Jul 23. pii: jnumed.115.157990.
    PubMed     Text format     Abstract available


  449. LAU J, Liu Z, Lin KS, Pan J, et al
    Trimeric radiofluorinated sulfonamide derivatives to achieve in vivo selectivity for carbonic anhydrase IX-targeted PET imaging.
    J Nucl Med. 2015 Jul 23. pii: jnumed.114.153288.
    PubMed     Text format     Abstract available


  450. AYRES KL, Spottswood SE, Delbeke D, Price RR, et al
    Dose Optimization in Pediatric Bone Scintigraphy: Validation of the 2010 North American Consensus Guidelines.
    J Nucl Med. 2015 Jul 23. pii: jnumed.115.156141.
    PubMed     Text format     Abstract available


  451. SHURYAK I, Dadachova E
    New Approaches for Modeling Radiopharmaceutical Pharmacokinetics Using Continuous Distributions of Rates.
    J Nucl Med. 2015 Jul 23. pii: jnumed.115.160515.
    PubMed     Text format     Abstract available


  452. JENSEN P, Feng L, Law I, Svarer C, et al
    TSPO imaging in glioblastoma multiforme: A direct comparison between 123ICLINDE-SPECT, 18F-FET PET and gadolinium-enhanced MRI.
    J Nucl Med. 2015 Jul 16. pii: jnumed.115.158998.
    PubMed     Text format     Abstract available


  453. GRECCHI E, O' Doherty J, Veronese M, Tsoumpas C, et al
    Multimodal Partial Volume Correction - Application to 18F-Fluoride PET/CT bone metastases studies.
    J Nucl Med. 2015 Jul 16. pii: jnumed.115.160598.
    PubMed     Text format     Abstract available


  454. WERNER RA, Rischpler C, Onthank D, Lapa C, et al
    Retention Kinetics of the 18F-labeled Sympathetic Nerve PET Tracer LMI1195: Comparison with 11C-HED and 123I-MIBG.
    J Nucl Med. 2015 Jul 16. pii: jnumed.115.158493.
    PubMed     Text format     Abstract available


  455. KIESS A, Minn I, Chen Y, Hobbs RF, et al
    Auger Radiopharmaceutical Therapy Targeting Prostate-Specific Membrane Antigen.
    J Nucl Med. 2015 Jul 16. pii: jnumed.115.155929.
    PubMed     Text format     Abstract available


  456. KIMURA Y, Ichise M, Ito H, Shimada H, et al
    PET Quantification of Tau Pathology in Human Brain with 11C-PBB3.
    J Nucl Med. 2015 Jul 16. pii: jnumed.115.160127.
    PubMed     Text format     Abstract available


  457. PAN Q, Li J, Li F, Zhou D, et al
    Characterizing POEMS syndrome with 18F-Fludeoxyglucose positron emission tomography/computed tomography.
    J Nucl Med. 2015 Jul 16. pii: jnumed.115.160507.
    PubMed     Text format     Abstract available


  458. BYRNE K, Siva S, Chait L, Callahan J, et al
    15-year Experience of 18F-FDG PET Imaging in Response Assessment and Re-staging after Definitive Treatment of Merkel Cell Carcinoma.
    J Nucl Med. 2015 Jul 9. pii: jnumed.115.158261.
    PubMed     Text format     Abstract available


  459. TRAGARDH M, Moller N, Sorensen M
    Methodological Considerations when Performing Quantitative 18F-FDG PET/CT Studies of Hepatic Glucose Metabolism in Healthy Subjects.
    J Nucl Med. 2015 Jul 9. pii: jnumed.115.154211.
    PubMed     Text format     Abstract available


  460. NGUYEN NC, Vercher-Conejero JL, Sattar A, Miller M, et al
    Image quality and diagnostic performance of a digital PET prototype in patients with oncologic diseases: Initial experience and comparison with analog PET.
    J Nucl Med. 2015 Jul 9. pii: jnumed.114.148338.
    PubMed     Text format     Abstract available


  461. CHAMPION L, Lerebours F, Alberini JL, Fourme E, et al
    18F-FDG PET/CT to predict response to neoadjuvant chemotherapy and prognosis in inflammatory breast cancer.
    J Nucl Med. 2015 Jul 9. pii: jnumed.115.158287.
    PubMed     Text format     Abstract available


  462. TEOH EJ, McGowan DR, Macpherson RE, Bradley KM, et al
    Phantom and clinical evaluation of the Bayesian penalized likelihood reconstruction algorithm Q.Clear on an LYSO PET/CT system.
    J Nucl Med. 2015 Jul 9. pii: jnumed.115.159301.
    PubMed     Text format     Abstract available


  463. BRODOV Y, Gransar H, Dey D, Shalev A, et al
    Combined Quantitative Assessment of Myocardial Perfusion and Coronary Artery Calcium Score by Hybrid 82Rb PET/CT Improves Detection of Coronary Artery Disease.
    J Nucl Med. 2015 Jul 9. pii: jnumed.114.153429.
    PubMed     Text format     Abstract available


  464. MANSOR MS, Boellaard R, Froklage FE, Bakker ED, et al
    Quantification of dynamic 11C-Phenytoin PET studies.
    J Nucl Med. 2015 Jul 1. pii: jnumed.115.158055.
    PubMed     Text format     Abstract available


  465. DEN HOLLANDER MW, Bensch F, Glaudemans AW, Oude Munnink TH, et al
    TGF-beta antibody uptake in recurrent high grade glioma imaged with 89Zr-fresolimumab PET.
    J Nucl Med. 2015 Jul 1. pii: jnumed.115.154401.
    PubMed     Text format     Abstract available


  466. ROHREN EM, Etchebehere E, Araujo J, Hobbs BP, et al
    DETERMINATION OF SKELETAL TUMOR BURDEN ON 18F-FLUORIDE PET/CT.
    J Nucl Med. 2015 Jul 1. pii: jnumed.115.156026.
    PubMed     Text format     Abstract available


  467. SODERLUND TA, Chaal J, Tjio G, Totman JJ, et al
    Beyond 18F-FDG: characterization of PET/CT and PET/MR scanners for a comprehensive set of positron emitters of growing application - 18F, 11C, 89Zr, 124I, 68Ga and 90Y.
    J Nucl Med. 2015 Jul 1. pii: jnumed.115.156711.
    PubMed     Text format     Abstract available


  468. KAWADA K, Toda K, Nakamoto Y, Iwamoto M, et al
    Relationship between FDG-PET/CT scans and KRAS Mutations in Metastatic Colorectal Cancer.
    J Nucl Med. 2015 Jul 1. pii: jnumed.115.160614.
    PubMed     Text format     Abstract available


  469. CARBONELL F, Zijdenbos AP, Charil A, Grand'Maison M, et al
    Optimal Target Region for Subject Classification based on Amyloid PET Images.
    J Nucl Med. 2015 Jul 1. pii: jnumed.115.158774.
    PubMed     Text format     Abstract available


  470. MOROZ MA, Zhang H, Lee J, Moroz E, et al
    Comparative Analysis of T Cell Imaging with Human Nuclear Reporter Genes.
    J Nucl Med. 2015;56:1055-60.
    PubMed     Text format     Abstract available


  471. LAVISSE S, Garcia-Lorenzo D, Peyronneau MA, Bodini B, et al
    Optimized Quantification of Translocator Protein Radioligand (1)(8)F-DPA-714 Uptake in the Brain of Genotyped Healthy Volunteers.
    J Nucl Med. 2015;56:1048-54.
    PubMed     Text format     Abstract available


  472. STRAUSS HW, Narula J, Nakahara T
    Finding Calcium in Noncalcified Lesions: (1)(8)F-Fluoride Offers Insights into Atheroma Evolution.
    J Nucl Med. 2015;56:974-5.
    PubMed     Text format    


  473. FAHEY F, Zukotynski K, Jadvar H, Capala J, et al
    Proceedings of the Second NCI-SNMMI Workshop on Targeted Radionuclide Therapy.
    J Nucl Med. 2015;56:1119-29.
    PubMed     Text format    


  474. MENDLER CT, Gehring T, Wester HJ, Schwaiger M, et al
    (8)(9)Zr-Labeled Versus (1)(2)(4)I-Labeled alphaHER2 Fab with Optimized Plasma Half-Life for High-Contrast Tumor Imaging In Vivo.
    J Nucl Med. 2015;56:1112-8.
    PubMed     Text format     Abstract available


  475. SOJKOVA J, Goh J, Bilgel M, Landman B, et al
    Voxelwise Relationships Between Distribution Volume Ratio and Cerebral Blood Flow: Implications for Analysis of beta-Amyloid Images.
    J Nucl Med. 2015;56:1042-7.
    PubMed     Text format     Abstract available


  476. BRAAT AJ, Smits ML, Braat MN, van den Hoven AF, et al
    (9)(0)Y Hepatic Radioembolization: An Update on Current Practice and Recent Developments.
    J Nucl Med. 2015;56:1079-87.
    PubMed     Text format     Abstract available


  477. JOUTSA J, Johansson J, Seppanen M, Noponen T, et al
    Dorsal-to-Ventral Shift in Midbrain Dopaminergic Projections and Increased Thalamic/Raphe Serotonergic Function in Early Parkinson Disease.
    J Nucl Med. 2015;56:1036-41.
    PubMed     Text format     Abstract available


  478. LE ROUX PY, Pelletier-Galarneau M, de Laroche R, Hofman MS, et al
    Pulmonary scintigraphy for the diagnosis of acute pulmonary embolism: a survey of current practices in Australia, Canada and France.
    J Nucl Med. 2015 Jul 1. pii: jnumed.115.157743.
    PubMed     Text format     Abstract available


    June 2015
  479. PENG F, Muzik O, Gatson J, Kernie S, et al
    Detection of Increased 64Cu uptake in Traumatic Brain Injury with 64CuCl2-PET/CT.
    J Nucl Med. 2015 Jun 25. pii: jnumed.115.154575.
    PubMed     Text format     Abstract available


  480. MORIGI JJ, Stricker P, Van Leeuwen P, Tang R, et al
    Prospective Comparison of the detection rate of18F-Fluoromethylcholine and 68Ga-PSMA-HBED PET/CT in men with prostate cancer with rising PSA post curative treatment, being considered for targeted therapy.
    J Nucl Med. 2015 Jun 25. pii: jnumed.115.160382.
    PubMed     Text format     Abstract available


  481. PEREZ-MEDINA C, Tang J, Abdel-Atti D, Hogstad B, et al
    PET Imaging of Tumor-Associated Macrophages with 89Zr-labeled HDL Nanoparticles.
    J Nucl Med. 2015 Jun 25. pii: jnumed.115.158956.
    PubMed     Text format     Abstract available


  482. ULANER GA, Riedl C
    Reply: Breast cancer staging: to which women 18FDG-PET/CT should be offered?
    J Nucl Med. 2015 Jun 25. pii: jnumed.115.161042.
    PubMed     Text format    


  483. KINAHAN PE, Mankoff D, Linden H
    The value of establishing the quantitative accuracy of PET/CT imaging.
    J Nucl Med. 2015 Jun 18. pii: jnumed.115.159178.
    PubMed     Text format    


  484. GATES VL, Singh N, Lewandowski R, Spies SM, et al
    INTRA-ARTERIAL HEPATIC SPECT/CT IMAGING USING TECHNETIUM-99M MACRO-AGGREGATED ALBUMIN IN PREPARATION FOR RADIOEMBOLIZATION.
    J Nucl Med. 2015 Jun 18. pii: jnumed.114.153346.
    PubMed     Text format     Abstract available


  485. ZANOTTI-FREGONARA P, Laforest R, Wallis JW
    Fetal radiation dose from [18F]-FDG in pregnant patients imaged with PET, PET/CT and PET/MRI.
    J Nucl Med. 2015 Jun 18. pii: jnumed.115.157032.
    PubMed     Text format     Abstract available


  486. LUBBERINK M, Golla SS, Jonasson M, Rubin K, et al
    The water-perfusable tissue fraction of colorectal cancer metastases is increased by the selective PDGF-receptor inhibitor imatinib but not the IL-1 receptor antagonist anakinra, a study using serial dynamic 15O-water PET.
    J Nucl Med. 2015 Jun 11. pii: jnumed.114.151894.
    PubMed     Text format     Abstract available


  487. ETCHEBEHERE E, Araujo JC, Fox PS, Swanston NM, et al
    Prognostic factors in patients treated with radium-223: the role of skeletal tumor burden on baseline 18F-fluoride-PET/CT in predicting overall survival.
    J Nucl Med. 2015 Jun 11. pii: jnumed.115.158626.
    PubMed     Text format     Abstract available


  488. BLYKERS A, Schoonooghe S, Xavier C, D'hoe K, et al
    PET imaging of MMR-expressing macrophages in tumor stroma using 18F-radiolabeled camelid single-domain antibody fragments.
    J Nucl Med. 2015 Jun 11. pii: jnumed.115.156828.
    PubMed     Text format     Abstract available


  489. ROWE SP, Gage KL, Faraj SF, Macura K, et al
    18F-DCFBC PET/CT for PSMA-based Detection and Characterization of Primary Prostate Cancer.
    J Nucl Med. 2015 Jun 11. pii: jnumed.115.154336.
    PubMed     Text format     Abstract available


  490. KIM DY, Kim HS, Reder S, Zheng JH, et al
    Comparison of 18F-labeled Fluoroalkylphosphonium Cations with 13N-NH3 for PET Myocardial Perfusion Imaging.
    J Nucl Med. 2015 Jun 11. pii: jnumed.115.156794.
    PubMed     Text format     Abstract available


  491. HEIDARI P, Esfahani S, Turker NS, Wong G, et al
    Imaging of the secreted extracellular periostin, an important marker of invasion in tumor microenvironment in esophageal cancer.
    J Nucl Med. 2015 Jun 11. pii: jnumed.115.156216.
    PubMed     Text format     Abstract available


  492. KAUHANEN S, Rinta-Kiikka I, Kemppainen J, Gronroos J, et al
    The diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT), multidetector row computed tomography (MDCT) and magnetic resonance imaging (MRI) in the diagnosis of pancreatic cysts; a prospectiv
    J Nucl Med. 2015 Jun 4. pii: jnumed.114.148940.
    PubMed     Text format     Abstract available


  493. HIRATA K, Hattori N, Takeuchi W, Shiga T, et al
    Metabolic activity of red nucleus and its correlation with cerebral cortex and cerebellum - a study using a high-resolution semiconductor PET system.
    J Nucl Med. 2015 Jun 4. pii: jnumed.114.152504.
    PubMed     Text format     Abstract available


  494. HUSBY JA, Reitan BC, Biermann M, Trovik J, et al
    Metabolic tumor volume (MTV) at 18F-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography (18F-FDG-PET/CT) improves preoperative identification of high-risk endometrial carcinoma patients.
    J Nucl Med. 2015 Jun 4. pii: jnumed.115.159913.
    PubMed     Text format     Abstract available


  495. GROHEUX D, Hindie E
    Breast cancer staging: to which women 18FDG-PET/CT should be offered?
    J Nucl Med. 2015 Jun 4. pii: jnumed.115.160945.
    PubMed     Text format    


  496. CHEN YJ, Rosario BL, Mowrey W, Laymon CM, et al
    PiB Relative Delivery (R1) as a Proxy of Relative Cerebral Blood Flow: Quantitative Evaluation Using Single Session 15O-Water and 11C-PiB PET.
    J Nucl Med. 2015 Jun 4. pii: jnumed.114.152405.
    PubMed     Text format     Abstract available


  497. PALNER M, Shen B, Jeon J, Lin J, et al
    Preclinical kinetic analysis of the Caspase-3/7 PET tracer 18F-C-SNAT for imaging tumor apoptosis after chemotherapeutic treatment.
    J Nucl Med. 2015 Jun 4. pii: jnumed.115.155259.
    PubMed     Text format     Abstract available


  498. DIMITRIU-LEEN AC, Scholte AJ, Jacobson AF
    123I-MIBG SPECT for Evaluation of Patients with Heart Failure.
    J Nucl Med. 2015;56 Suppl 4:25S-30S.
    PubMed     Text format     Abstract available


  499. HAROLDS JA, Oates ME, Guiberteau MJ, Ghesani M, et al
    New training pathways to dual certification in nuclear medicine and radiology.
    J Nucl Med. 2015;56:17N-8N.
    PubMed     Text format    


  500. GARIN E, Edeline J
    Reply: Modifying the Poor Prognosis Associated with 18F-FDG-Avid NET with Peptide Receptor Chemo-Radionuclide Therapy (PRCRT).
    J Nucl Med. 2015;56:969.
    PubMed     Text format    


  501. HOFMAN MS, Michael M, Kashyap R, Hicks RJ, et al
    Modifying the Poor Prognosis Associated with 18F-FDG-Avid NET with Peptide Receptor Chemo-Radionuclide Therapy (PRCRT).
    J Nucl Med. 2015;56:968-9.
    PubMed     Text format    


  502. BORGQUIST R, Singh JP
    An electrophysiologist perspective on risk stratification in heart failure: can better understanding of the condition of the cardiac sympathetic nervous system help?
    J Nucl Med. 2015;56 Suppl 4:59S-64S.
    PubMed     Text format     Abstract available


  503. ABDULGHANI M, Duell J, Smith M, Chen W, et al
    Global and Regional Myocardial Innervation Before and After Ablation of Drug-Refractory Ventricular Tachycardia Assessed with 123I-MIBG.
    J Nucl Med. 2015;56 Suppl 4:52S-58S.
    PubMed     Text format     Abstract available


  504. LEVINE A, Hecht HS
    Cardiac CT Angiography in Congestive Heart Failure.
    J Nucl Med. 2015;56 Suppl 4:46S-51S.
    PubMed     Text format     Abstract available


  505. JACOBSON AF, Narula J
    Introduction to cardiac neuronal imaging: a clinical perspective.
    J Nucl Med. 2015;56 Suppl 4:3S-6S.
    PubMed     Text format     Abstract available


  506. NAKAJIMA K, Nakata T
    Cardiac 123I-MIBG Imaging for Clinical Decision Making: 22-Year Experience in Japan.
    J Nucl Med. 2015;56 Suppl 4:11S-19S.
    PubMed     Text format     Abstract available



  507. Deadlines for Appropriate Use Criteria loom; resolutions remain unclear.
    J Nucl Med. 2015;56:23N-24N.
    PubMed     Text format    


  508. SEGALL G
    ABNM Maintenance of Certification: Getting It Right.
    J Nucl Med. 2015;56:19N.
    PubMed     Text format    


  509. DHAWAN V, Robeson W, Bjelke D, Chaly T, et al
    Human Radiation Dosimetry for the N-Methyl-D-Aspartate Receptor Radioligand 11C-CNS5161.
    J Nucl Med. 2015;56:869-72.
    PubMed     Text format     Abstract available


  510. FAHEY FH, Ziniel SI, Manion D, Treves ST, et al
    Effects of Image Gently and the North American guidelines: administered activities in children at 13 North American pediatric hospitals.
    J Nucl Med. 2015;56:962-7.
    PubMed     Text format     Abstract available


  511. MONCAYO VM, Aarsvold JN, Alazraki NP
    Lymphoscintigraphy and sentinel nodes.
    J Nucl Med. 2015;56:901-7.
    PubMed     Text format     Abstract available


  512. PRINCE JF, van Rooij R, Bol GH, de Jong HW, et al
    Safety of a Scout Dose Preceding Hepatic Radioembolization with 166Ho Microspheres.
    J Nucl Med. 2015;56:817-23.
    PubMed     Text format     Abstract available


  513. JIANG L, Tu Y, Kimura RH, Habte F, et al
    64Cu-Labeled Divalent Cystine Knot Peptide for Imaging Carotid Atherosclerotic Plaques.
    J Nucl Med. 2015;56:939-44.
    PubMed     Text format     Abstract available


  514. JUNG JJ, Razavian M, Challa AA, Nie L, et al
    Multimodality and molecular imaging of matrix metalloproteinase activation in calcific aortic valve disease.
    J Nucl Med. 2015;56:933-8.
    PubMed     Text format     Abstract available


  515. HERRMANN K, Bluemel C, Weineisen M, Schottelius M, et al
    Biodistribution and radiation dosimetry for a probe targeting prostate-specific membrane antigen for imaging and therapy.
    J Nucl Med. 2015;56:855-61.
    PubMed     Text format     Abstract available


  516. VAN BERKEL A, Rao JU, Lenders JW, Pellegata NS, et al
    Semiquantitative 123I-Metaiodobenzylguanidine Scintigraphy to Distinguish Pheochromocytoma and Paraganglioma from Physiologic Adrenal Uptake and Its Correlation with Genotype-Dependent Expression of Catecholamine Transporters.
    J Nucl Med. 2015;56:839-46.
    PubMed     Text format     Abstract available


  517. PELLETIER-GALARNEAU M, Sogbein OO, Pham X, Hao J, et al
    Multicenter validation of a shortened gastric-emptying protocol.
    J Nucl Med. 2015;56:873-6.
    PubMed     Text format     Abstract available


  518. LIN C, Kume K, Mori T, Martinez ME, et al
    Predictive Value of Early-Stage Uptake of 3'-Deoxy-3'-18F-Fluorothymidine in Cancer Cells Treated with Charged Particle Irradiation.
    J Nucl Med. 2015;56:945-50.
    PubMed     Text format     Abstract available


    May 2015
  519. PAULUS DH, Quick HH, Geppert C, Fenchel M, et al
    Whole-Body PET/MR Imaging: Quantitative Evaluation of a Novel Model-Based MR Attenuation Correction Method Including Bone.
    J Nucl Med. 2015 May 29. pii: jnumed.115.156000.
    PubMed     Text format     Abstract available


  520. ANTWI K, Fani M, Nicolas G, Rottenburger C, et al
    Localization of hidden Insulinomas with 68Ga-DOTA-exendin-4 PET/CT: A Pilot Study.
    J Nucl Med. 2015 May 21. pii: jnumed.115.157768.
    PubMed     Text format     Abstract available


  521. ROWE SP, Vicente E, Anizan N, Wang H, et al
    Repeatability of radiotracer uptake in normal abdominal organs with 111In-pentetreotide quantitative SPECT/CT.
    J Nucl Med. 2015 May 14. pii: jnumed.115.155358.
    PubMed     Text format     Abstract available


  522. HWANG H, Jeong HS, Oh PS, Na KS, et al
    Improving Cerebral Blood Flow through Liposomal Delivery of Angiogenic Peptides: Potential of 18F-FDG PET Imaging in Ischemic Stroke Treatment.
    J Nucl Med. 2015 May 14. pii: jnumed.115.154443.
    PubMed     Text format     Abstract available


  523. JADVAR H
    PSMA PET in Prostate Cancer.
    J Nucl Med. 2015 May 14. pii: jnumed.115.157339.
    PubMed     Text format    


  524. BLASI F, Oliveira BL, Rietz TA, Rotile NJ, et al
    Radiation dosimetry of the fibrin-binding probe 64Cu-FBP8 and its feasibility for positron emission tomography imaging of deep vein thrombosis and pulmonary embolism in rats.
    J Nucl Med. 2015 May 14. pii: jnumed.115.157982.
    PubMed     Text format     Abstract available


  525. HUSMANN L, Sah BR, Scherrer A, Burger IA, et al
    18F-FDG-PET/CT FOR THERAPY CONTROL IN VASCULAR GRAFT INFECTIONS: A FIRST FEASIBILITY STUDY.
    J Nucl Med. 2015 May 14. pii: jnumed.115.156265.
    PubMed     Text format     Abstract available


  526. NIEDERMOSER S, Chin J, Waengler C, Kostikov A, et al
    In vivo Evaluation of 18F-SiFAlin modified TATE: A Potential Challenge for 68Ga- DOTATATE, the Clinical Gold Standard for Somatostatin Receptor Imaging with Positron Emission Tomography (PET).
    J Nucl Med. 2015 May 14. pii: jnumed.114.149583.
    PubMed     Text format     Abstract available


  527. CHATALIC KL, Veldhoven-Zweistra J, Bolkestein M, Hoeben S, et al
    A novel 111In-labeled anti-PSMA nanobody for targeted SPECT/CT imaging of prostate cancer.
    J Nucl Med. 2015 May 14. pii: jnumed.115.156729.
    PubMed     Text format     Abstract available


  528. DELBEKE D
    The Era of Evidence-Based Medicine: What Are the Implications for JNM and Other Imaging Journals?
    J Nucl Med. 2015;56:28A.
    PubMed     Text format    


  529. HERSCOVITCH P
    Amyloid Imaging Coverage with Evidence Development and the IDEAS Study.
    J Nucl Med. 2015;56:20N.
    PubMed     Text format    


  530. KHALKHALI I
    Ismael Mena, MD, 1928-2015.
    J Nucl Med. 2015;56:19N.
    PubMed     Text format    


  531. CONTI PS
    Walter Wolf, PhD, 1931-2014.
    J Nucl Med. 2015;56:13N.
    PubMed     Text format    


  532. ZAMAN RT, Kosuge H, Carpenter C, Sun C, et al
    Scintillating balloon-enabled fiber-optic system for radionuclide imaging of atherosclerotic plaques.
    J Nucl Med. 2015;56:771-7.
    PubMed     Text format     Abstract available


  533. LAVERMAN P, van der Geest T, Terry SY, Gerrits D, et al
    Immuno-PET and Immuno-SPECT of Rheumatoid Arthritis with Radiolabeled Anti-Fibroblast Activation Protein Antibody Correlates with Severity of Arthritis.
    J Nucl Med. 2015;56:778-83.
    PubMed     Text format     Abstract available


  534. HINDIE E, Zanotti-Fregonara P, Tabarin A, Rubello D, et al
    The role of radionuclide imaging in the surgical management of primary hyperparathyroidism.
    J Nucl Med. 2015;56:737-44.
    PubMed     Text format     Abstract available


  535. FAN Z, Harold D, Pasqualetti G, Williams J, et al
    Can Studies of Neuroinflammation in a TSPO Genetic Subgroup (HAB or MAB) Be Applied to the Entire AD Cohort?
    J Nucl Med. 2015;56:707-13.
    PubMed     Text format     Abstract available


  536. KHAIRNAR A, Marchand F, Vidal A, Etienne M, et al
    99mTc-NTP 15-5 Imaging for Cartilage Involvement in Experimental Rheumatoid Arthritis: Comparison with Routinely Used Molecular Imaging Methods and Sensitivity to Chronic Nonsteroidal Antiinflammatory Drug Treatment.
    J Nucl Med. 2015;56:798-804.
    PubMed     Text format     Abstract available


  537. HAUSNER SH, Bauer N, Hu LY, Knight LM, et al
    The Effect of Bi-Terminal PEGylation of an Integrin alphavbeta(6)-Targeted (1)(8)F Peptide on Pharmacokinetics and Tumor Uptake.
    J Nucl Med. 2015;56:784-90.
    PubMed     Text format     Abstract available


  538. FAZIO P, Svenningsson P, Forsberg A, Jonsson EG, et al
    Quantitative Analysis of (1)(8)F-(E)-N-(3-Iodoprop-2-Enyl)-2beta-Carbofluoroethoxy-3beta-(4'-Methyl-Phenyl ) Nortropane Binding to the Dopamine Transporter in Parkinson Disease.
    J Nucl Med. 2015;56:714-20.
    PubMed     Text format     Abstract available


  539. GLAUDEMANS AW, Slart RH, van Dijl JM, van Oosten M, et al
    Molecular imaging of infectious and inflammatory diseases: a terra incognita.
    J Nucl Med. 2015;56:659-61.
    PubMed     Text format    


    April 2015
  540. BENESOVA M, Schafer M, Bauder-Wust U, Afshar-Oromieh A, et al
    Preclinical evaluation of a tailor-made DOTA-conjugated PSMA inhibitor with optimized linker moiety for imaging and endoradiotherapy of prostate cancer.
    J Nucl Med. 2015 Apr 16. pii: jnumed.114.147413.
    PubMed     Text format     Abstract available


  541. GROHEUX D, Sanna A, Majdoub M, de Cremoux P, et al
    Baseline tumor 18FDG uptake and modifications after 2 cycles of neoadjuvant chemotherapy are prognostic of outcome in ER+/HER2- breast cancer.
    J Nucl Med. 2015 Apr 16. pii: jnumed.115.154138.
    PubMed     Text format     Abstract available



  542. Canadian NRU extended; medical isotope partnership announced.
    J Nucl Med. 2015;56:9N.
    PubMed     Text format    


  543. PAPPAS V
    SNMMI leadership update: SNMMI annual meeting heads to Baltimore.
    J Nucl Med. 2015;56:13N.
    PubMed     Text format    


  544. FAHEY F
    History Corner: from the new SNMMI historian.
    J Nucl Med. 2015;56:11N.
    PubMed     Text format    


  545. DORBALA S, Blankstein R, Skali H, Park MA, et al
    Approaches to reducing radiation dose from radionuclide myocardial perfusion imaging.
    J Nucl Med. 2015;56:592-9.
    PubMed     Text format     Abstract available


  546. HUA C, Merchant TE, Li X, Li Y, et al
    Establishing age-associated normative ranges of the cerebral 18F-FDG uptake ratio in children.
    J Nucl Med. 2015;56:575-9.
    PubMed     Text format     Abstract available


  547. BANERJEE SR, Foss CA, Pullambhatla M, Wang Y, et al
    Preclinical evaluation of 86Y-labeled inhibitors of prostate-specific membrane antigen for dosimetry estimates.
    J Nucl Med. 2015;56:628-34.
    PubMed     Text format     Abstract available


  548. KOCH CJ, Evans SM
    Pharmacokinetic and pharmacodynamic modifiers of EF5 uptake and binding.
    J Nucl Med. 2015;56:653.
    PubMed     Text format    


  549. CHITNENI SK, Bida GT, Zalutsky MR, Dewhirst MW, et al
    Reply: Pharmacokinetic and Pharmacodynamic Modifiers of EF5 Uptake and Binding.
    J Nucl Med. 2015;56:653-4.
    PubMed     Text format    


    March 2015
  550. DALM SU, Martens JW, Sieuwerts AM, van Deurzen CH, et al
    IN-VITRO AND IN-VIVO APPLICATION OF RADIOLABELED GASTRIN RELEASING PEPTIDE RECEPTOR LIGANDS IN BREAST CANCER.
    J Nucl Med. 2015 Mar 19. pii: jnumed.114.153023.
    PubMed     Text format     Abstract available


  551. KNOOP K, Schwenk N, Schmohl K, Muller A, et al
    Mesenchymal stem cell (MSC)-mediated, tumor stroma-targeted radioiodine therapy of metastatic colon cancer using the sodium iodide symporter as theranostic gene.
    J Nucl Med. 2015 Mar 5. pii: jnumed.114.146662.
    PubMed     Text format     Abstract available


  552. FREY KA
    Amyloid imaging in dementia: contribution or confusion?
    J Nucl Med. 2015;56:331-2.
    PubMed     Text format    


  553. THRALL JH
    Misinterpretation of 18F-FDG studies in oncology.
    J Nucl Med. 2015;56:494.
    PubMed     Text format    


  554. DELBEKE D
    JNM update for 2014.
    J Nucl Med. 2015;56:25A.
    PubMed     Text format    


  555. HERSCOVITCH P
    SNMMI leadership update: reaching out to develop a unified voice.
    J Nucl Med. 2015;56:16N.
    PubMed     Text format    



  556. Enrollment trends in technologist training.
    J Nucl Med. 2015;56:15N.
    PubMed     Text format    



  557. SNMMI industry forum created to work together on areas of promise.
    J Nucl Med. 2015;56:13N.
    PubMed     Text format    


  558. HERRMANN K, Lapa C, Wester HJ, Schottelius M, et al
    Biodistribution and radiation dosimetry for the chemokine receptor CXCR4-targeting probe 68Ga-pentixafor.
    J Nucl Med. 2015;56:410-6.
    PubMed     Text format     Abstract available


  559. GARIN E, Rolland Y, Edeline J, Icard N, et al
    Personalized dosimetry with intensification using 90Y-loaded glass microsphere radioembolization induces prolonged overall survival in hepatocellular carcinoma patients with portal vein thrombosis.
    J Nucl Med. 2015;56:339-46.
    PubMed     Text format     Abstract available


  560. DELSO G, Wiesinger F, Sacolick LI, Kaushik SS, et al
    Clinical evaluation of zero-echo-time MR imaging for the segmentation of the skull.
    J Nucl Med. 2015;56:417-22.
    PubMed     Text format     Abstract available


  561. KLUPP E, Grimmer T, Tahmasian M, Sorg C, et al
    Prefrontal hypometabolism in Alzheimer disease is related to longitudinal amyloid accumulation in remote brain regions.
    J Nucl Med. 2015;56:399-404.
    PubMed     Text format     Abstract available


  562. CABELLO J, Lukas M, Forster S, Pyka T, et al
    MR-based attenuation correction using ultrashort-echo-time pulse sequences in dementia patients.
    J Nucl Med. 2015;56:423-9.
    PubMed     Text format     Abstract available


  563. CZUPRYNA J, Kachur AV, Blankemeyer E, Popov AV, et al
    Cerenkov-specific contrast agents for detection of pH in vivo.
    J Nucl Med. 2015;56:483-8.
    PubMed     Text format     Abstract available


  564. STEPHENSON NA, Holland JP, Kassenbrock A, Yokell DL, et al
    Iodonium ylide-mediated radiofluorination of 18F-FPEB and validation for human use.
    J Nucl Med. 2015;56:489-92.
    PubMed     Text format     Abstract available


  565. TIMMERMAND OV, Tran TA, Strand SE, Axelsson J, et al
    Intratherapeutic biokinetic measurements, dosimetry parameter estimates, and monitoring of treatment efficacy using cerenkov luminescence imaging in preclinical radionuclide therapy.
    J Nucl Med. 2015;56:444-9.
    PubMed     Text format     Abstract available


  566. LAUTAMAKI R, Sasano T, Higuchi T, Nekolla SG, et al
    Multiparametric molecular imaging provides mechanistic insights into sympathetic innervation impairment in the viable infarct border zone.
    J Nucl Med. 2015;56:457-63.
    PubMed     Text format     Abstract available


  567. GIORGETTI A, Burchielli S, Positano V, Kovalski G, et al
    Dynamic 3D analysis of myocardial sympathetic innervation: an experimental study using 123I-MIBG and a CZT camera.
    J Nucl Med. 2015;56:464-9.
    PubMed     Text format     Abstract available


  568. NAHIMI A, Jakobsen S, Munk OL, Vang K, et al
    Mapping alpha2 adrenoceptors of the human brain with 11C-yohimbine.
    J Nucl Med. 2015;56:392-8.
    PubMed     Text format     Abstract available


    February 2015
  569. ZHANG G, Li J, Wang X, Ma Y, et al
    The reverse Warburg effect and 18F-FDG uptake in non-small cell lung cancer A549 in mice: A pilot study.
    J Nucl Med. 2015 Feb 26. pii: jnumed.114.148254.
    PubMed     Text format     Abstract available


  570. SAH BR, Burger IA, Schibli R, Friebe M, et al
    Dosimetry and first clinical evaluation of the new 18F radiolabeled Bombesin Analogue BAY 864367 in patients with prostate cancer.
    J Nucl Med. 2015 Feb 12. pii: jnumed.114.147116.
    PubMed     Text format     Abstract available


  571. VERWER EE, Oprea-Lager DE, van den Eertwegh AJ, van Moorselaar RJ, et al
    Quantification of 18F-fluorocholine kinetics in patients with prostate cancer.
    J Nucl Med. 2015 Feb 12. pii: jnumed.114.148007.
    PubMed     Text format     Abstract available



  572. Abstracts of the AACR/SNMMI State-of-the-Art Molecular Imaging in Cancer Biology and Therapy, February 11-14, 2015, San Diego, CA.
    J Nucl Med. 2015;56 Suppl 1:3A-28.
    PubMed     Text format    


    May 2014
  573. PERISINAKIS K, Seimenis I, Tzedakis A, Damilakis J, et al
    Perfusion Scintigraphy Versus 256-Slice CT Angiography in Pregnant Patients Suspected of Pulmonary Embolism: Comparison of Radiation Risks.
    J Nucl Med. 2014 May 29. pii: jnumed.114.137968.
    PubMed     Text format     Abstract available


  574. VAN GOOL MH, Aukema TS, Schaake EE, Rijna H, et al
    Timing of Metabolic Response Monitoring During Erlotinib Treatment in Non-Small Cell Lung Cancer.
    J Nucl Med. 2014.
    PubMed     Text format     Abstract available


    April 2014
  575. LUTJE S, Rijpkema M, Franssen GM, Fracasso G, et al
    Dual-Modality Image-Guided Surgery of Prostate Cancer with a Radiolabeled Fluorescent Anti-PSMA Monoclonal Antibody.
    J Nucl Med. 2014.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Nuclear Medicine is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: